Congenital fibrosis of the extraocular muscles (CFEOM) is a congenital, non-progressive restrictive ophthalmoplegia with blepharoptosis, in which the eyes are held in a fixed, usually infraducted position and cannot be elevated above the horizontal midline. Despite the name, CFEOM is not a primary myopathy: it is a congenital cranial dysinnervation disorder (CCDD). The primary lesion lies in the developing oculomotor (cranial nerve III) and trochlear (cranial nerve IV) nuclei and their axons; neuropathology and high-resolution orbital MRI show absent or hypoplastic ocular motor nerves and loss of the corresponding alpha motor neurons, with the extraocular muscle atrophy and "fibrosis" that gives the disorder its name arising secondarily from denervation. Aberrant reinnervation of denervated muscles by misrouted branches of the surviving oculomotor nerve produces the synkinetic and paradoxical residual eye movements that are characteristic of the disorder. Four principal molecular routes converge on this lesion: gain-of-function missense variants in the anterograde kinesin KIF21A that attenuate its autoinhibition and stall superior-division oculomotor axons (CFEOM1, and the dominant CFEOM3B); recessive loss of the homeodomain transcription factor PHOX2A/ARIX, which is required to specify the nIII/nIV motor nuclei (CFEOM2); heterozygous missense variants in the neuron-specific beta-tubulins TUBB3 and TUBB2B that alter microtubule dynamics and microtubule-kinesin interaction (CFEOM3, with variable CNS involvement); and recessive loss of COL25A1 (CFEOM5). CFEOM sits in the CCDD family alongside Duane retraction syndrome, Moebius syndrome, and horizontal gaze palsy with progressive scoliosis, all of which arise from maldevelopment or miswiring of ocular motor cranial nerves rather than from a primary muscle defect. Management is supportive and surgical - inferior rectus recession to correct the chin-up head posture, ptosis suspension surgery, refractive correction, and amblyopia therapy - and does not restore normal ocular motility.
Ask a research question about Congenital Fibrosis of the Extraocular Muscles. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Congenital Fibrosis of the Extraocular Muscles
creation_date: "2026-08-20T00:00:00Z"
category: Mendelian
disease_term:
preferred_term: congenital fibrosis of extraocular muscles
term:
id: MONDO:0007614
label: congenital fibrosis of extraocular muscles
description: >-
Congenital fibrosis of the extraocular muscles (CFEOM) is a congenital,
non-progressive restrictive ophthalmoplegia with blepharoptosis, in which the
eyes are held in a fixed, usually infraducted position and cannot be elevated
above the horizontal midline. Despite the name, CFEOM is not a primary
myopathy: it is a congenital cranial dysinnervation disorder (CCDD). The
primary lesion lies in the developing oculomotor (cranial nerve III) and
trochlear (cranial nerve IV) nuclei and their axons; neuropathology and
high-resolution orbital MRI show absent or hypoplastic ocular motor nerves and
loss of the corresponding alpha motor neurons, with the extraocular muscle
atrophy and "fibrosis" that gives the disorder its name arising secondarily
from denervation. Aberrant reinnervation of denervated muscles by misrouted
branches of the surviving oculomotor nerve produces the synkinetic and
paradoxical residual eye movements that are characteristic of the disorder.
Four principal molecular routes converge on this lesion: gain-of-function
missense variants in the anterograde kinesin KIF21A that attenuate its
autoinhibition and stall superior-division oculomotor axons (CFEOM1, and the
dominant CFEOM3B); recessive loss of the homeodomain transcription factor
PHOX2A/ARIX, which is required to specify the nIII/nIV motor nuclei (CFEOM2);
heterozygous missense variants in the neuron-specific beta-tubulins TUBB3 and
TUBB2B that alter microtubule dynamics and microtubule-kinesin interaction
(CFEOM3, with variable CNS involvement); and recessive loss of COL25A1
(CFEOM5). CFEOM sits in the CCDD family alongside Duane retraction syndrome,
Moebius syndrome, and horizontal gaze palsy with progressive scoliosis, all of
which arise from maldevelopment or miswiring of ocular motor cranial nerves
rather than from a primary muscle defect. Management is supportive and
surgical - inferior rectus recession to correct the chin-up head posture,
ptosis suspension surgery, refractive correction, and amblyopia therapy - and
does not restore normal ocular motility.
parents:
- ocular motility disease
- congenital nervous system disorder
- hereditary neurological disease
- disorder of development or morphogenesis
inheritance:
- name: Autosomal dominant inheritance
description: >-
CFEOM1 and CFEOM3 (KIF21A, TUBB3, TUBB2B) are inherited in an autosomal
dominant manner; affected individuals are heterozygous for a missense
variant.
inheritance_term:
preferred_term: Autosomal dominant inheritance
term:
id: HP:0000006
label: Autosomal dominant inheritance
evidence:
- reference: PMID:14595441
reference_title: "Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Congenital fibrosis of the extraocular muscles type 1 (CFEOM1; OMIM
#135700) is an autosomal dominant strabismus disorder associated with
defects of the oculomotor nerve.
explanation: >-
Establishes CFEOM1, the commonest form, as an autosomal dominant disorder
of the oculomotor nerve.
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We report that eight heterozygous missense mutations in TUBB3, encoding
the neuron-specific beta-tubulin isotype III, result in a spectrum of
human nervous system disorders that we now call the TUBB3 syndromes.
explanation: >-
Heterozygous TUBB3 missense variants are sufficient to cause CFEOM3,
supporting autosomal dominant transmission of that subtype.
- name: Autosomal recessive inheritance
description: >-
CFEOM2 (PHOX2A/ARIX), CFEOM5 (COL25A1), and the Tukel syndrome variant are
inherited in an autosomal recessive manner, and have been described mainly in
consanguineous families.
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:14597037
reference_title: "A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Both parents and the unaffected siblings were heterozygous,and the two
affected siblings were homozygous for this mutation.
explanation: >-
Homozygous affected siblings with heterozygous unaffected parents
establishes autosomal recessive transmission of CFEOM2.
- reference: PMID:25500261
reference_title: "Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
we identified three mutations in collagen, type XXV, alpha 1 (COL25A1) in
individuals with autosomal-recessive inheritance of CCDD ophthalmic
phenotypes.
explanation: >-
Establishes autosomal recessive inheritance for the COL25A1 (CFEOM5) form.
references:
- reference: PMID:20301522
title: "Congenital Fibrosis of the Extraocular Muscles Overview."
tags:
- GeneReviews
- reference: PMID:9066352
title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
- reference: PMID:15671279
title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
- reference: PMID:14595441
title: "Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1)."
- reference: PMID:24656932
title: "Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling."
- reference: PMID:11600883
title: "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2."
- reference: PMID:20074521
title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
- reference: PMID:23001566
title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
- reference: PMID:25500261
title: "Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder."
- reference: PMID:15863670
title: "A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter."
- reference: PMID:31313749
title: "Congenital fibrosis of the extraocular muscles: review of recent literature."
- reference: PMID:31848785
title: "Surgical management of pediatric patients with congenital fibrosis of the extraocular muscles."
- reference: PMID:34081534
title: "Axonal Growth Abnormalities Underlying Ocular Cranial Nerve Disorders."
- reference: PMID:39033378
title: "Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders."
has_subtypes:
- name: CFEOM1
display_name: CFEOM1 (KIF21A, classic bilateral CFEOM)
classification: genetic
subtype_term:
preferred_term: congenital fibrosis of extraocular muscles type 1
term:
id: MONDO:0021083
label: congenital fibrosis of extraocular muscles type 1
genes:
- preferred_term: KIF21A
term:
id: hgnc:19349
label: KIF21A
description: >-
The classic and most common form. Autosomal dominant, fully penetrant, and
bilateral: both eyes are fixed in a downward (infraducted) position with
severe bilateral ptosis and inability to elevate either eye above the
horizontal midline. Caused by heterozygous missense variants in the kinesin
KIF21A, with recurrent hotspots in the third coiled-coil stalk domain
(p.R954W is by far the commonest allele, recurring across ancestries).
evidence:
- reference: PMID:14595441
reference_title: "Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We show that individuals with CFEOM1 harbor heterozygous missense
mutations in a kinesin motor protein encoded by KIF21A. We identified six
different mutations in 44 of 45 probands.
explanation: >-
Establishes heterozygous KIF21A missense variants as the cause of CFEOM1
in nearly all probands tested.
- reference: PMID:16365788
reference_title: "Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinically, each patient had congenital bilateral ptosis, an infraducted
primary position of each eye, and the inability to raise either eye above
midline.
explanation: >-
Defines the stereotyped bilateral CFEOM1 clinical picture in KIF21A
p.R954W carriers.
- name: CFEOM2
display_name: CFEOM2 (PHOX2A/ARIX, autosomal recessive)
classification: genetic
subtype_term:
preferred_term: fibrosis of extraocular muscles, congenital, 2
term:
id: MONDO:0011181
label: fibrosis of extraocular muscles, congenital, 2
genes:
- preferred_term: PHOX2A
term:
id: hgnc:691
label: PHOX2A
description: >-
Autosomal recessive form, described mainly in consanguineous Middle Eastern
families. Affected individuals have bilateral ptosis with the eyes fixed in
an exotropic (outward) rather than infraducted position and severe
limitation of all extraocular movements. Caused by biallelic loss of
PHOX2A/ARIX, a homeodomain transcription factor required for specification of
the oculomotor and trochlear motor nuclei.
evidence:
- reference: PMID:11600883
reference_title: "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Here, we report three mutations in ARIX (also known as PHOX2A) in four
CFEOM2 pedigrees.
explanation: >-
Identifies PHOX2A/ARIX as the CFEOM2 disease gene across four pedigrees.
- reference: PMID:14597037
reference_title: "A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The two affected siblings had bilateral ptosis and exotropia and severe
limitation of all extraocular movements.
explanation: >-
Documents the distinguishing exotropic primary position of CFEOM2.
- name: CFEOM3A
display_name: CFEOM3A (TUBB3, with or without extraocular involvement)
classification: genetic
subtype_term:
preferred_term: fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement
term:
id: MONDO:0010912
label: fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement
genes:
- preferred_term: TUBB3
term:
id: hgnc:20772
label: TUBB3
description: >-
Autosomal dominant, more variable and often asymmetric or unilateral form
caused by heterozygous missense variants in TUBB3, the neuron-specific
beta-tubulin isotype III. Unlike CFEOM1, the eyes are not always infraducted
and one eye may be spared. Some TUBB3 alleles add extraocular features -
intellectual and behavioural impairment, facial weakness, and a later-onset
axonal sensorimotor polyneuropathy - together with commissural and
corticospinal tract dysgenesis on neuroimaging. See the separate
TUBB3-related Tubulinopathy entry for the wider TUBB3 syndrome spectrum.
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Each mutation causes the ocular motility disorder CFEOM3, whereas some
also result in intellectual and behavioral impairments, facial paralysis,
and/or later-onset axonal sensorimotor polyneuropathy.
explanation: >-
Defines CFEOM3 as the constant ocular phenotype of TUBB3 missense variants
with variable additional neurological features.
- name: CFEOM3B
display_name: CFEOM3B (KIF21A)
classification: genetic
subtype_term:
preferred_term: fibrosis of extraocular muscles, congenital, 3b
term:
id: MONDO:0800209
label: fibrosis of extraocular muscles, congenital, 3b
genes:
- preferred_term: KIF21A
term:
id: hgnc:19349
label: KIF21A
description: >-
A CFEOM3-pattern (variable, potentially unilateral or asymmetric, eyes not
obligately infraducted) phenotype caused by KIF21A variants rather than
TUBB3, showing that the same KIF21A allele can produce either the classic
CFEOM1 pattern or a CFEOM3 pattern within and between families.
evidence:
- reference: PMID:27513105
reference_title: "KIF21A mutation in two Chinese families with congenital fibrosis of the extraocular muscles type 1 and 3."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The results indicated that, in the patients with CFEOM1 and CFEOM3, the
disease was caused by the same KIF21A gene mutation.
explanation: >-
Demonstrates that a single recurrent KIF21A allele underlies both the
CFEOM1 and CFEOM3 clinical patterns.
- name: CFEOM3C
display_name: CFEOM3C (13q12.11-linked)
classification: genetic
subtype_term:
preferred_term: fibrosis of extraocular muscles, congenital, 3c
term:
id: MONDO:0012262
label: fibrosis of extraocular muscles, congenital, 3c
description: >-
A locus-defined CFEOM3 subtype mapped by linkage in a family without a
KIF21A or TUBB3 variant. It is retained here as a distinct nosological
entity because the causal gene at the locus is not established, so the
subtype cannot yet be folded into a gene-defined class.
- name: CFEOM5
display_name: CFEOM5 (COL25A1, autosomal recessive)
classification: genetic
subtype_term:
preferred_term: fibrosis of extraocular muscles, congenital, 5
term:
id: MONDO:0014538
label: fibrosis of extraocular muscles, congenital, 5
genes:
- preferred_term: COL25A1
term:
id: hgnc:18603
label: COL25A1
description: >-
Autosomal recessive CCDD with a CFEOM ophthalmic phenotype caused by
biallelic COL25A1 variants that reduce protein stability or level. COL25A1
encodes CLAC-P, a transmembrane collagen implicated in oculomotor neuron
development, placing this subtype outside the cytoskeletal and
transcription-factor mechanisms of the other subtypes.
evidence:
- reference: PMID:25500261
reference_title: "Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our data suggest that lack of COL25A1 might interfere with molecular
pathways involved in oculomotor neuron development, leading to CCDD
phenotypes.
explanation: >-
Assigns the COL25A1 subtype to the same oculomotor-neuron developmental
mechanism as the rest of the CFEOM spectrum.
- name: Tukel syndrome
display_name: Tukel syndrome (CFEOM with postaxial ulnar hand anomalies)
classification: genetic
subtype_term:
preferred_term: Tukel syndrome
term:
id: MONDO:0012270
label: Tukel syndrome
description: >-
An autosomal recessive syndromic variant in which non-progressive
restrictive ophthalmoplegia with blepharoptosis is accompanied by postaxial
(ulnar) oligodactyly or oligosyndactyly of the hands. Described in a large
consanguineous Turkish family and mapped by linkage to chromosome 21qter;
the causal gene remains unidentified. The co-occurrence of a cranial
dysinnervation phenotype with a posterior limb-patterning defect is the
feature that distinguishes it from isolated CFEOM.
evidence:
- reference: PMID:15863670
reference_title: "A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The postaxial oligodactyly/oligosyndactyly of the hands was more severe on
the right side.
explanation: >-
Defines the ulnar hand anomaly that distinguishes Tukel syndrome from
isolated CFEOM.
- reference: PMID:15863670
reference_title: "A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A genome-wide scan established linkage of this new autosomal recessive
syndrome to a locus on chromosome 21qter.
explanation: >-
Establishes the recessive inheritance and 21qter locus of Tukel syndrome.
pathophysiology:
- name: KIF21A Kinesin Autoinhibition Loss
biological_scale: MOLECULAR
description: >-
KIF21A is an anterograde kinesin whose motor activity is normally restrained
by an intramolecular autoinhibitory interaction between its third coiled-coil
stalk and its motor domain. The recurrent CFEOM1 missense variants cluster in
exactly these two elements and attenuate that autoinhibition, so the motor is
inappropriately active. This is a gain-of-function lesion, not haploinsufficiency,
which is why heterozygous missense variants are pathogenic while KIF21A null
alleles are not a recognised cause of CFEOM.
molecular_functions:
- preferred_term: KIF21A microtubule motor activity
term:
id: GO:0003777
label: microtubule motor activity
modifier: GAIN_OF_FUNCTION
cell_types:
- preferred_term: oculomotor alpha motor neuron
term:
id: CL:0008038
label: alpha motor neuron
evidence:
- reference: PMID:24656932
reference_title: "Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
We establish a gain-of-function mechanism and find that human motor or
stalk mutations attenuate Kif21a autoinhibition, providing in vivo
evidence for mammalian kinesin autoregulation.
explanation: >-
Establishes attenuated KIF21A autoinhibition as the gain-of-function
molecular lesion in CFEOM1.
- reference: PMID:14595441
reference_title: "Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The primary mutational hotspots are in the stalk domain, highlighting an
important new role for KIF21A and its stalk in the formation of the
oculomotor axis.
explanation: >-
Localises the CFEOM1 variants to the stalk domain that mediates
autoinhibition.
downstream:
- target: Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
causal_link_type: DIRECT
description: >-
A disinhibited KIF21A motor perturbs the axonal cytoskeleton of the
developing oculomotor nerve, and its superior-division axons fail to
advance normally.
evidence:
- reference: PMID:24656932
reference_title: "Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
We demonstrate that Kif21a knockin mice harboring the most common human
mutation develop CFEOM. The developing axons of the oculomotor nerve's
superior division stall in the proximal nerve; the growth cones enlarge,
extend excessive filopodia, and assume random trajectories.
explanation: >-
A knockin mouse carrying the common human allele shows the stalling and
growth-cone disorganisation this edge asserts.
- name: PHOX2A-Dependent Oculomotor and Trochlear Nucleus Specification Failure
biological_scale: CELLULAR
description: >-
PHOX2A (ARIX) is a homeodomain transcription factor required to specify the
midbrain oculomotor (nIII) and trochlear (nIV) motor nuclei. Biallelic
loss-of-function variants remove that determinant, so the motor neuron pools
that should innervate the extraocular muscles are never properly formed. This
is the CFEOM2 route into the shared downstream lesion, and it is upstream of
axon guidance rather than a guidance defect itself.
molecular_functions:
- preferred_term: PHOX2A homeodomain transcription factor activity
term:
id: GO:0003700
label: DNA-binding transcription factor activity
modifier: LOSS_OF_FUNCTION
biological_processes:
- preferred_term: oculomotor nerve development
term:
id: GO:0021557
label: oculomotor nerve development
modifier: DECREASED
- preferred_term: trochlear nerve development
term:
id: GO:0021558
label: trochlear nerve development
modifier: DECREASED
cell_types:
- preferred_term: oculomotor and trochlear alpha motor neuron
term:
id: CL:0008038
label: alpha motor neuron
evidence:
- reference: PMID:11600883
reference_title: "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
ARIX encodes a homeodomain transcription factor protein previously shown
to be required for nIII/nIV development in mouse and zebrafish.
explanation: >-
Identifies the developmental role of PHOX2A/ARIX in the oculomotor and
trochlear nuclei that biallelic loss removes.
- reference: PMID:11600883
reference_title: "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
These findings confirm the hypothesis that CFEOM2 results from the
abnormal development of nIII/nIV (ref. 7) and emphasize a critical role
for ARIX in the development of these midbrain motor nuclei.
explanation: >-
Directly attributes CFEOM2 to abnormal development of the nIII/nIV motor
nuclei.
- reference: PMID:34081534
reference_title: "Axonal Growth Abnormalities Underlying Ocular Cranial Nerve Disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
These disorders can arise through one of two mechanisms: (a) defective
motor neuron specification, usually by loss of a transcription factor
necessary for brainstem patterning, or (b) axon growth and guidance
abnormalities of the oculomotor, trochlear, and abducens nerves.
explanation: >-
Places the PHOX2A lesion in the transcription-factor specification arm of
the two recognised CCDD mechanisms.
downstream:
- target: Hypoplasia of the Oculomotor and Trochlear Nerves
causal_link_type: DIRECT
description: >-
Motor nuclei that are never specified cannot send out a normal nerve, so
the nIII and nIV trunks are absent or hypoplastic.
evidence:
- reference: PMID:11600883
reference_title: "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neuropathologic studies indicate that these disorders may result from
the maldevelopment of the oculomotor (nIII), trochlear (nIV) and
abducens (nVI) cranial nerve nuclei.
explanation: >-
Links nuclear maldevelopment to the cranial nerve lesion that defines
the congenital fibrosis syndromes.
- name: Beta-Tubulin Microtubule Dysfunction in Cranial Motor Neurons
biological_scale: MOLECULAR
description: >-
TUBB3 and TUBB2B encode neuron-enriched beta-tubulin isotypes that
heterodimerise with alpha-tubulin to build the dynamic microtubules of the
growing axon and its growth cone. The CFEOM3-causing missense variants
impair heterodimer formation, alter microtubule dynamic instability, and in a
subset also disrupt the interface through which kinesin motors engage the
microtubule lattice. The convergence of this arm with the KIF21A arm on the
same clinical phenotype - one lesion in the track, the other in the motor -
is the strongest mechanistic argument that CFEOM is a disorder of axonal
transport and guidance.
molecular_functions:
- preferred_term: beta-tubulin structural constituent of the neuronal microtubule
term:
id: GO:0005200
label: structural constituent of cytoskeleton
modifier: DYSREGULATED
- preferred_term: microtubule-kinesin interaction
term:
id: GO:0019894
label: kinesin binding
modifier: DECREASED
biological_processes:
- preferred_term: tubulin heterodimer formation
term:
id: GO:0007021
label: tubulin complex assembly
modifier: DECREASED
cell_types:
- preferred_term: cranial motor neuron
term:
id: CL:0000100
label: motor neuron
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Modeling each mutation in yeast tubulin demonstrates that all alter
dynamic instability whereas a subset disrupts the interaction of
microtubules with kinesin motors.
explanation: >-
Establishes altered microtubule dynamics in every allele and disrupted
microtubule-kinesin interaction in a subset.
- reference: PMID:23001566
reference_title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
TUBB2B-E421K αβ-heterodimers are incorporated into the microtubule
network where they alter microtubule dynamics and can reduce kinesin
localization.
explanation: >-
Shows the CFEOM-causing TUBB2B allele acts through the same
dynamics-and-kinesin mechanism as the TUBB3 alleles.
downstream:
- target: Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
causal_link_type: DIRECT
description: >-
Microtubules whose dynamics and kinesin engagement are perturbed cannot
support normal growth-cone steering in the developing ocular motor nerves.
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
A knock-in disease mouse model reveals axon guidance defects without
evidence of cortical cell migration abnormalities.
explanation: >-
The knock-in model isolates axon guidance, not neuronal migration, as
the consequence of the TUBB3 lesion.
- target: Commissural and Corticospinal Axon Guidance Failure
causal_link_type: DIRECT
description: >-
The same tubulin lesion also perturbs guidance of callosal and other
long-range projection axons, which is why some TUBB3 and TUBB2B alleles
add central nervous system features to the ocular phenotype.
evidence:
- reference: PMID:23001566
reference_title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Expression of exogenous Tubb2b-E421K in developing callosal projection
neurons is sufficient to perturb homotopic connectivity, without
affecting neuronal production or migration.
explanation: >-
Shows the tubulin lesion is sufficient to disrupt callosal connectivity
independently of migration.
- name: COL25A1 Loss in Oculomotor Neuron Development
biological_scale: MOLECULAR
description: >-
COL25A1 encodes CLAC-P, a neuronal transmembrane collagen. Biallelic
variants that reduce its stability or abundance perturb the molecular
programme of oculomotor neuron development and alter the levels of
axon-guidance-associated proteins including soluble APP and TUBB3 itself,
connecting this recessive subtype back to the shared cytoskeletal arm.
cell_types:
- preferred_term: oculomotor neuron
term:
id: CL:0000100
label: motor neuron
biological_processes:
- preferred_term: oculomotor nerve development
term:
id: GO:0021557
label: oculomotor nerve development
modifier: DECREASED
evidence:
- reference: PMID:25500261
reference_title: "Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We further detected altered levels of sAPP (neuronal protein involved in
axon guidance and synaptogenesis) and TUBB3 (encoded by TUBB3, which is
mutated in CFEOM3) as a result of null mutations in COL25A1.
explanation: >-
Connects COL25A1 loss to the axon-guidance machinery shared with the other
CFEOM subtypes.
downstream:
- target: Hypoplasia of the Oculomotor and Trochlear Nerves
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- Disturbed oculomotor neuron development
- Altered levels of axon-guidance-associated proteins including sAPP and TUBB3
description: >-
Loss of COL25A1 interferes with the developmental programme that builds
the ocular motor nerves.
evidence:
- reference: PMID:25500261
reference_title: "Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our data suggest that lack of COL25A1 might interfere with molecular
pathways involved in oculomotor neuron development, leading to CCDD
phenotypes.
explanation: >-
States the inferred causal route from COL25A1 loss to a cranial
dysinnervation phenotype.
- name: Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
biological_scale: CELLULAR
description: >-
The convergent cellular lesion of the cytoskeletal CFEOM subtypes. Axons of
the oculomotor nerve, and most consistently those of its superior division
that supply the levator palpebrae superioris and superior rectus, stall in
the proximal nerve. Their growth cones enlarge, extend excessive filopodia,
and take random trajectories instead of following their stereotyped path to
the orbit; axons of the inferior division reach the orbit but branch
ectopically. This selective vulnerability of the developing oculomotor nerve
to perturbations of the axon cytoskeleton is what makes an otherwise
ubiquitously expressed motor or tubulin lesion present as an isolated eye
movement disorder.
biological_processes:
- preferred_term: motor neuron axon guidance
term:
id: GO:0008045
label: motor neuron axon guidance
modifier: DYSREGULATED
- preferred_term: axon extension of the oculomotor nerve
term:
id: GO:0048675
label: axon extension
modifier: DECREASED
cell_types:
- preferred_term: oculomotor alpha motor neuron
term:
id: CL:0008038
label: alpha motor neuron
evidence:
- reference: PMID:24656932
reference_title: "Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Inferior division axons reach the orbit but branch ectopically.
explanation: >-
Documents the divergent fate of inferior-division axons alongside the
stalled superior division.
- reference: PMID:24656932
reference_title: "Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
highlights a selective vulnerability of the developing oculomotor nerve to
perturbations of the axon cytoskeleton
explanation: >-
States the selective vulnerability that explains the restricted phenotype.
- reference: PMID:34081534
reference_title: "Axonal Growth Abnormalities Underlying Ocular Cranial Nerve Disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Abnormalities of axon growth and guidance are often limited to a single
nerve or subdivision, even when the causative gene is ubiquitously
expressed.
explanation: >-
Establishes that the guidance defect is restricted to one nerve or nerve
subdivision despite ubiquitous expression of the causal gene.
downstream:
- target: Hypoplasia of the Oculomotor and Trochlear Nerves
causal_link_type: DIRECT
description: >-
Axons that stall or never arrive leave a structurally thin or absent nerve
trunk and, over time, loss of the corresponding motor neurons.
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neuroimaging reveals a spectrum of abnormalities including hypoplasia of
oculomotor nerves and dysgenesis of the corpus callosum, anterior
commissure, and corticospinal tracts.
explanation: >-
Human neuroimaging confirms oculomotor nerve hypoplasia as the
structural consequence of the guidance defect.
- target: Aberrant Reinnervation of Extraocular Muscles
causal_link_type: DIRECT
description: >-
Misrouted and ectopically branching oculomotor axons reach muscles they do
not normally supply, most characteristically the lateral rectus.
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Subjects with the R954W and R954Q substitutions frequently exhibited
A-pattern strabismus, with misinnervation of the lateral rectus muscle
by an oculomotor nerve branch.
explanation: >-
Orbital MRI directly demonstrates oculomotor misinnervation of the
lateral rectus in CFEOM1.
- name: Hypoplasia of the Oculomotor and Trochlear Nerves
biological_scale: TISSUE
description: >-
The defining structural lesion of CFEOM and the point at which every
molecular route converges. Autopsy of a chromosome-12-linked (CFEOM1) family
showed absence of the superior division of the oculomotor nerve together with
its alpha motor neurons; high-resolution orbital MRI in genotyped KIF21A
carriers shows small or absent orbital motor nerves, with the oculomotor
nerve most severely hypoplastic and the abducens also affected. The lesion is
therefore not confined to nIII, and its extent is wider than the classic
superior-division description implies.
biological_processes:
- preferred_term: oculomotor nerve morphogenesis
term:
id: GO:0021622
label: oculomotor nerve morphogenesis
modifier: DECREASED
- preferred_term: cranial nerve development
term:
id: GO:0021545
label: cranial nerve development
modifier: DECREASED
cell_types:
- preferred_term: oculomotor alpha motor neuron
term:
id: CL:0008038
label: alpha motor neuron
evidence:
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
There is an absence of the superior division of the oculomotor nerve and
its corresponding alpha motor neurons, and abnormalities of the levator
palpebrae superioris and rectus superior (the muscles innervated by the
superior division of the oculomotor nerve).
explanation: >-
Human neuropathology establishes the missing nerve division and motor
neuron pool as the primary lesion.
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In affected subjects, MRI demonstrated atrophy of the levator palpebrae
superioris and superior rectus EOMs and small or absent orbital motor
nerves. The oculomotor nerve was most severely hypoplastic, but the
abducens was also affected.
explanation: >-
Genotyped in vivo imaging confirms hypoplastic ocular motor nerves and
extends the lesion to the abducens.
downstream:
- target: Denervation-Driven Extraocular Muscle Maldevelopment and Fibrosis
causal_link_type: DIRECT
description: >-
Extraocular muscles that never receive normal innervation fail to develop
and become atrophic and fibrotic - the secondary event that gave the
disorder its misleading name.
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
These findings suggest that neuronal disease is primary in CFEOM1, with
myopathy arising secondary to abnormal innervation and minimal rectus
pulley abnormality secondary to reduced EOM forces.
explanation: >-
States the causal direction this edge encodes: neurogenic primary
lesion, myopathy secondary.
- name: Denervation-Driven Extraocular Muscle Maldevelopment and Fibrosis
biological_scale: TISSUE
description: >-
Deprived of their motor innervation during development, the affected
extraocular muscles - most consistently the levator palpebrae superioris and
superior rectus - are hypoplastic and atrophic, show increased internal
nuclei and central mitochondrial clumping, and are progressively replaced by
fibrous connective tissue. The muscles become mechanically restrictive, which
is why forced duction testing is positive and why the ophthalmoplegia is
restrictive rather than simply paralytic. Because the fibrosis is a
consequence of denervation rather than a primary myopathy, no myopathic
therapy addresses it.
biological_processes:
- preferred_term: extraocular skeletal muscle development
term:
id: GO:0002074
label: extraocular skeletal muscle development
modifier: DECREASED
- preferred_term: skeletal muscle atrophy
term:
id: GO:0014732
label: skeletal muscle atrophy
modifier: INCREASED
- preferred_term: collagen fibril organization in the fibrotic muscle
term:
id: GO:0030199
label: collagen fibril organization
modifier: INCREASED
cell_types:
- preferred_term: extraocular skeletal muscle fiber
term:
id: CL:0008002
label: skeletal muscle fiber
- preferred_term: fibroblast
term:
id: CL:0000057
label: fibroblast
evidence:
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In addition, increased numbers of internal nuclei and central
mitochondrial clumping are found in other extraocular muscles, suggesting
that the muscle pathology extends beyond the muscles innervated by the
superior division of cranial nerve III.
explanation: >-
Documents the secondary myopathic changes and their extent beyond the
denervated superior-division muscles.
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: >-
It has been generally thought that these clinical abnormalities result
from myopathic fibrosis of the extraocular muscles.
explanation: >-
Names the primary-myopathy model that the same study's neuropathology
refutes, establishing the fibrosis as secondary.
downstream:
- target: Restrictive Non-Progressive Ophthalmoplegia with Ptosis
causal_link_type: DIRECT
description: >-
Hypoplastic, fibrotic and mechanically tethered extraocular muscles fix
the globe and prevent elevation, and a denervated levator produces ptosis.
evidence:
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Congenital fibrosis of the extraocular muscles is an autosomal dominant
congenital disorder characterized by bilateral ptosis, restrictive
external ophthalmoplegia with the eyes partially or completely fixed in
an infraducted (downward) and strabismic position, and markedly limited
and aberrant residual eye movements.
explanation: >-
Ties the muscle lesion to the defining restrictive ophthalmoplegia and
ptosis.
- name: Aberrant Reinnervation of Extraocular Muscles
biological_scale: TISSUE
description: >-
Denervated extraocular muscles are secondarily and inappropriately
reinnervated by misrouted branches of the surviving oculomotor nerve, most
characteristically the lateral rectus. Because the aberrantly supplied muscle
now fires with its new parent nerve rather than with its normal partner, the
eye makes paradoxical, synkinetic movements - upshoots and downshoots on
attempted adduction, A-pattern deviation, and in the rarest form synergistic
divergence, in which attempted adduction produces abduction of both eyes.
This is the same aberrant-reinnervation logic that produces globe retraction
in Duane retraction syndrome.
biological_processes:
- preferred_term: aberrant motor neuron axon guidance to extraocular muscle
term:
id: GO:0008045
label: motor neuron axon guidance
modifier: DYSREGULATED
- preferred_term: neuromuscular junction development at the misinnervated muscle
term:
id: GO:0007528
label: neuromuscular junction development
modifier: DYSREGULATED
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Orbital imaging in CFEOM1 due to various amino acid substitutions in the
kinesin KIF21A demonstrates consistent abnormalities of motor and sensory
innervation in the orbit.
explanation: >-
Establishes consistent aberrant orbital innervation in genotyped CFEOM1.
- reference: PMID:34081534
reference_title: "Axonal Growth Abnormalities Underlying Ocular Cranial Nerve Disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Additionally, when one nerve is absent, its normal target muscles attract
other motor neurons.
explanation: >-
States the mechanism by which denervated extraocular muscles recruit
aberrant innervation from a surviving nerve.
downstream:
- target: Restrictive Non-Progressive Ophthalmoplegia with Ptosis
causal_link_type: DIRECT
description: >-
Synkinetic co-firing of aberrantly innervated muscles adds the aberrant
residual eye movements that accompany the restriction.
evidence:
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
markedly limited and aberrant residual eye movements
explanation: >-
Names the aberrant residual movements attributable to misinnervation.
- name: Commissural and Corticospinal Axon Guidance Failure
biological_scale: TISSUE
description: >-
In the TUBB3 and TUBB2B subtypes the tubulin lesion is not confined to the
ocular motor nerves. Long-range projection axons are also misrouted,
producing dysgenesis of the corpus callosum, anterior commissure, and
corticospinal tracts, and, for the TUBB2B E421K allele, polymicrogyria
alongside the CFEOM. This arm is what converts an isolated eye movement
disorder into a syndromic tubulinopathy, and it is the reason CFEOM3 carries
the extraocular features that CFEOM1 does not.
biological_processes:
- preferred_term: axon guidance of commissural and corticospinal projections
term:
id: GO:0007411
label: axon guidance
modifier: DYSREGULATED
cell_types:
- preferred_term: callosal projection neuron
term:
id: CL:0000540
label: neuron
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neuroimaging reveals a spectrum of abnormalities including hypoplasia of
oculomotor nerves and dysgenesis of the corpus callosum, anterior
commissure, and corticospinal tracts.
explanation: >-
Documents the commissural and corticospinal dysgenesis that accompanies
the ocular lesion in TUBB3 disease.
- reference: PMID:23001566
reference_title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Diffusion tensor imaging of brains of affected family members reveals
aberrations in the trajectories of commissural projection neurons,
implying a paucity of homotopic connections.
explanation: >-
Human diffusion imaging shows the commissural misrouting in the TUBB2B
CFEOM family.
- name: Restrictive Non-Progressive Ophthalmoplegia with Ptosis
biological_scale: ORGANISM
description: >-
The clinical endpoint of the cascade. The eyes are held in a fixed, usually
infraducted position and cannot be raised above the horizontal midline,
ocular ductions are severely restricted in all directions, and there is
bilateral blepharoptosis with poor levator function. The deficit is present
from birth and does not progress, which distinguishes it from the acquired
and progressive external ophthalmoplegias. Because both eyes are effectively
immobile, patients adopt a compensatory chin-up head posture to see through
the small residual field of gaze, and are at risk of amblyopia and exposure
keratopathy.
evidence:
- reference: PMID:31313749
reference_title: "Congenital fibrosis of the extraocular muscles: review of recent literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Congenital fibrosis of the extraocular muscles (CFEOM) is caused by
abnormal development of the innervation of extraocular muscles.
explanation: >-
A contemporary review states the neurogenic causal direction that this
chain encodes.
- reference: PMID:16365788
reference_title: "Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinically, each patient had congenital bilateral ptosis, an infraducted
primary position of each eye, and the inability to raise either eye above
midline.
explanation: >-
Describes the stereotyped clinical endpoint in genotyped patients.
phenotypes:
- name: Congenital Fibrosis of the Extraocular Muscles
description: >-
The defining clinical entity: congenital, non-progressive ophthalmoplegia
with multiple extraocular muscle restrictions, ptosis, and variable
restriction of horizontal and vertical eye movements.
phenotype_term:
preferred_term: Congenital fibrosis of extraocular muscles
term:
id: HP:0001491
label: Congenital fibrosis of extraocular muscles
temporality: CHRONIC
evidence:
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Congenital fibrosis of the extraocular muscles is an autosomal dominant
congenital disorder characterized by bilateral ptosis, restrictive
external ophthalmoplegia with the eyes partially or completely fixed in an
infraducted (downward) and strabismic position, and markedly limited and
aberrant residual eye movements.
explanation: >-
States the defining clinical syndrome of congenital restrictive
ophthalmoplegia with ptosis.
- name: Bilateral Congenital Ptosis
description: >-
Severe bilateral blepharoptosis with poor levator function, present from
birth. It reflects denervation and hypoplasia of the levator palpebrae
superioris supplied by the superior division of the oculomotor nerve, and it
compounds the visual deficit produced by the immobile eyes.
phenotype_term:
preferred_term: Ptosis
term:
id: HP:0000508
label: Ptosis
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Subjects with CFEOM1 had severe bilateral blepharoptosis, limited
supraduction, and variable ophthalmoplegia.
explanation: >-
Documents severe bilateral ptosis in a genotyped CFEOM1 cohort.
- name: Restrictive External Ophthalmoplegia
description: >-
Severe limitation of ocular ductions in all directions, classically with
inability to elevate either eye above the horizontal midline. Forced duction
testing is positive because the denervated muscles are mechanically
restrictive, distinguishing this from a purely paralytic ophthalmoplegia.
phenotype_term:
preferred_term: External ophthalmoplegia
term:
id: HP:0000544
label: External ophthalmoplegia
clinical_course: STABLE
evidence:
- reference: PMID:16365788
reference_title: "Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinically, each patient had congenital bilateral ptosis, an infraducted
primary position of each eye, and the inability to raise either eye above
midline.
explanation: >-
Documents the restricted ductions and fixed infraducted position in
genotyped CFEOM1 patients.
- reference: PMID:14597037
reference_title: "A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The two affected siblings had bilateral ptosis and exotropia and severe
limitation of all extraocular movements.
explanation: >-
Confirms the same severe restriction of all ductions in the recessive
CFEOM2 subtype.
- name: Strabismus
description: >-
Ocular misalignment is universal, but its direction is subtype-dependent: the
eyes are typically fixed in an infraducted and strabismic position in
CFEOM1, whereas an exotropic primary position is characteristic of CFEOM2.
phenotype_term:
preferred_term: Strabismus
term:
id: HP:0000486
label: Strabismus
evidence:
- reference: PMID:9066352
reference_title: "Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
restrictive external ophthalmoplegia with the eyes partially or completely
fixed in an infraducted (downward) and strabismic position
explanation: >-
Documents the fixed strabismic position of the eyes.
- name: Exotropia
subtype: CFEOM2
description: >-
Divergent ocular deviation. An exotropic rather than infraducted primary
position is the clinical marker that separates CFEOM2 from CFEOM1, and
A-pattern exotropia also emerges after inferior rectus recession in CFEOM1.
phenotype_term:
preferred_term: Exotropia
term:
id: HP:0000577
label: Exotropia
evidence:
- reference: PMID:14597037
reference_title: "A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The two affected siblings had bilateral ptosis and exotropia and severe
limitation of all extraocular movements.
explanation: >-
Documents exotropia in molecularly confirmed CFEOM2 siblings.
- name: Third Cranial Nerve Hypoplasia
description: >-
Hypoplasia or absence of the oculomotor nerve, the structural correlate of
the disorder. Demonstrated at autopsy as absence of the superior division and
its motor neurons, and in vivo by high-resolution orbital MRI and by
neuroimaging in TUBB3 disease.
phenotype_term:
preferred_term: Third cranial nerve hypoplasia
term:
id: HP:6000597
label: Third cranial nerve hypoplasia
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The oculomotor nerve was most severely hypoplastic, but the abducens was
also affected.
explanation: >-
Directly reports oculomotor nerve hypoplasia on orbital MRI in genotyped
CFEOM1.
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neuroimaging reveals a spectrum of abnormalities including hypoplasia of
oculomotor nerves and dysgenesis of the corpus callosum, anterior
commissure, and corticospinal tracts.
explanation: >-
Confirms oculomotor nerve hypoplasia in the TUBB3 (CFEOM3) subtype.
- name: Sixth Cranial Nerve Hypoplasia
description: >-
The abducens nerve is also small or absent on orbital MRI in CFEOM1, showing
that the dysinnervation is not restricted to the oculomotor nerve and
accounting for the horizontal as well as vertical duction deficits.
phenotype_term:
preferred_term: Sixth cranial nerve hypoplasia
term:
id: HP:6000596
label: Sixth cranial nerve hypoplasia
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The oculomotor nerve was most severely hypoplastic, but the abducens was
also affected.
explanation: >-
Reports abducens involvement alongside the oculomotor nerve in genotyped
CFEOM1.
- name: Compensatory Chin-Up Head Posture
description: >-
Because the eyes are fixed below the horizontal midline, the head is
extended (chin elevated) to bring the target into the small usable field of
gaze. Relief of this posture, rather than restoration of motility, is the
principal goal of inferior rectus recession.
phenotype_term:
preferred_term: Compensatory head posture
term:
id: HP:0031705
label: Compensatory head posture
evidence:
- reference: PMID:31848785
reference_title: "Surgical management of pediatric patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All the cases showed bilateral ptosis and a chin-up abnormal head posture
(AHP).
explanation: >-
Documents the chin-up compensatory head posture in a paediatric CFEOM
surgical series.
- name: Refractive Error
category: Ophthalmologic
description: >-
Refractive error occurs in CFEOM and is reported as variable in severity
across affected individuals. It is curated because it is one of the two
amblyogenic factors this entry already treats, and because the anomalous
globe position and chronic head posture that follow the dysinnervation
plausibly contribute to it -- though no source curated here demonstrates
that causal step, so no downstream edge is asserted.
phenotype_term:
preferred_term: Refractive error
term:
id: HP:0000539
label: Abnormality of refraction
evidence:
- reference: PMID:7724178
reference_title: "Congenital fibrosis of the vertically acting extraocular muscles. A new group of dominantly inherited ocular fibrosis with radiologic findings."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Refractive error and amblyopia also were variable"
explanation: >-
Documents refractive error in the reported CFEOM cohort. No frequency band
is asserted: "variable" describes spread, not a proportion, and per the
frequency SOP that does not support a FrequencyEnum value.
- name: Amblyopia
description: >-
Amblyopia is a recognised and variable complication, driven by the
combination of ptotic lid occlusion, ocular misalignment, and associated
refractive error, and is a target of occlusion or penalization therapy.
phenotype_term:
preferred_term: Amblyopia
term:
id: HP:0000646
label: Amblyopia
evidence:
- reference: PMID:7724178
reference_title: "Congenital fibrosis of the vertically acting extraocular muscles. A new group of dominantly inherited ocular fibrosis with radiologic findings."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Refractive error and amblyopia also were variable.
explanation: >-
Reports amblyopia, of variable degree, in a dominantly inherited
congenital ocular fibrosis pedigree.
- name: Corneal Scarring from Exposure Keratopathy
description: >-
An immobile, infraducted globe with an absent Bell phenomenon and poor lid
closure leaves the cornea chronically exposed, producing superficial
keratopathy and, in many patients, corneal scarring. This is a preventable
cause of visual loss that is independent of the motility deficit itself.
phenotype_term:
preferred_term: Corneal scarring
term:
id: HP:0000559
label: Corneal scarring
evidence:
- reference: PMID:7724178
reference_title: "Congenital fibrosis of the vertically acting extraocular muscles. A new group of dominantly inherited ocular fibrosis with radiologic findings."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All affected members showed superficial keratopathy, many with corneal
scarring.
explanation: >-
Documents superficial keratopathy in all affected members and corneal
scarring in many.
- name: Optic Nerve Hypoplasia
description: >-
Subclinical but statistically robust reduction in optic nerve size on orbital
MRI in CFEOM1, indicating that the dysinnervation extends to the sensory as
well as the motor apparatus of the orbit.
phenotype_term:
preferred_term: Optic nerve hypoplasia
term:
id: HP:0000609
label: Optic nerve hypoplasia
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Subjects with CFEOM1 exhibited subclinical but highly significant
reduction from normal in mean optic nerve size (P < 0.001).
explanation: >-
Quantifies the reduction in optic nerve size that this phenotype records.
- name: Abnormal Corpus Callosum Morphology
subtype: CFEOM3A
description: >-
Dysgenesis of the corpus callosum, together with the anterior commissure and
corticospinal tracts, on neuroimaging in the TUBB3 subtype. The finding is
dysgenesis rather than frank agenesis, and reflects misrouting of commissural
projection axons by the same tubulin lesion that misroutes the ocular motor
axons.
phenotype_term:
preferred_term: Abnormal corpus callosum morphology
term:
id: HP:0001273
label: Abnormal corpus callosum morphology
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neuroimaging reveals a spectrum of abnormalities including hypoplasia of
oculomotor nerves and dysgenesis of the corpus callosum, anterior
commissure, and corticospinal tracts.
explanation: >-
Reports corpus callosum dysgenesis on neuroimaging in TUBB3 disease.
- name: Polymicrogyria
description: >-
Cortical malformation seen with the TUBB2B E421K allele, which segregates
with CFEOM in the same family. It marks the boundary between the pure
dysinnervation phenotype and the wider tubulinopathy spectrum.
phenotype_term:
preferred_term: Polymicrogyria
term:
id: HP:0002126
label: Polymicrogyria
evidence:
- reference: PMID:23001566
reference_title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We have identified a novel inherited heterozygous missense mutation in
TUBB2B that results in an E421K amino acid substitution in a family who
segregates congenital fibrosis of the extraocular muscles (CFEOM) with
polymicrogyria.
explanation: >-
Documents co-segregation of polymicrogyria with CFEOM in the TUBB2B
family.
- name: Facial Palsy
subtype: CFEOM3A
description: >-
Facial weakness accompanies the ocular phenotype in a subset of TUBB3
alleles, extending the cranial dysinnervation beyond the ocular motor nerves.
phenotype_term:
preferred_term: Facial palsy
term:
id: HP:0010628
label: Facial palsy
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Each mutation causes the ocular motility disorder CFEOM3, whereas some
also result in intellectual and behavioral impairments, facial paralysis,
and/or later-onset axonal sensorimotor polyneuropathy.
explanation: >-
Lists facial paralysis among the allele-dependent extraocular features of
TUBB3 disease.
- name: Peripheral Axonal Neuropathy
subtype: CFEOM3A
description: >-
A later-onset axonal sensorimotor polyneuropathy occurs with a subset of
TUBB3 alleles. It is the one feature of the CFEOM spectrum that is
progressive, in contrast to the static ocular phenotype.
phenotype_term:
preferred_term: Peripheral axonal neuropathy
term:
id: HP:0003477
label: Peripheral axonal neuropathy
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Each mutation causes the ocular motility disorder CFEOM3, whereas some
also result in intellectual and behavioral impairments, facial paralysis,
and/or later-onset axonal sensorimotor polyneuropathy.
explanation: >-
Documents the later-onset axonal sensorimotor polyneuropathy of some TUBB3
alleles.
- name: Intellectual Disability
subtype: CFEOM3A
description: >-
Intellectual and behavioural impairment occurs with some, but not all, TUBB3
alleles; it is absent from CFEOM1 and is one of the features that separates
the syndromic from the isolated forms.
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Each mutation causes the ocular motility disorder CFEOM3, whereas some
also result in intellectual and behavioral impairments, facial paralysis,
and/or later-onset axonal sensorimotor polyneuropathy.
explanation: >-
Reports intellectual and behavioural impairment as an allele-dependent
feature of TUBB3 disease.
- name: Postaxial Oligodactyly
subtype: Tukel syndrome
description: >-
Postaxial (ulnar) oligodactyly of the hands, asymmetric and more severe on
the right in the original pedigree. Its co-occurrence with restrictive
ophthalmoplegia defines the Tukel syndrome variant.
phenotype_term:
preferred_term: Postaxial oligodactyly
term:
id: HP:0006210
label: Postaxial oligodactyly
evidence:
- reference: PMID:15863670
reference_title: "A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The postaxial oligodactyly/oligosyndactyly of the hands was more severe on
the right side.
explanation: >-
Documents postaxial oligodactyly of the hands in the Tukel syndrome
pedigree.
- name: Syndactyly
subtype: Tukel syndrome
description: >-
Oligosyndactyly of the hands accompanies the postaxial digit reduction in the
Tukel syndrome variant.
phenotype_term:
preferred_term: Syndactyly
term:
id: HP:0001159
label: Syndactyly
evidence:
- reference: PMID:15863670
reference_title: "A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The postaxial oligodactyly/oligosyndactyly of the hands was more severe on
the right side.
explanation: >-
Records the oligosyndactyly component of the Tukel hand anomaly.
genetic:
- name: KIF21A
association: Causative
relationship_type: CAUSATIVE
variant_origin: GERMLINE
subtype: CFEOM1
gene_term:
preferred_term: KIF21A (anterograde kinesin motor)
term:
id: hgnc:19349
label: KIF21A
variants:
- name: KIF21A c.2860C>T (p.Arg954Trp)
gene:
preferred_term: KIF21A
term:
id: hgnc:19349
label: KIF21A
type: missense variant
description: >-
The recurrent CFEOM1 allele, in exon 21 of the third coiled-coil stalk
domain, found heterozygously across unrelated families of many ancestries.
It acts by attenuating KIF21A autoinhibition, a gain of function, rather
than by reducing protein activity.
evidence:
- reference: PMID:16365788
reference_title: "Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All affected members had a heterozygous mutation of the KIF21A gene in
exon 21 (R954W).
explanation: >-
Documents the recurrent heterozygous exon 21 p.R954W allele.
evidence:
- reference: PMID:14595441
reference_title: "Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We show that individuals with CFEOM1 harbor heterozygous missense
mutations in a kinesin motor protein encoded by KIF21A. We identified six
different mutations in 44 of 45 probands.
explanation: >-
Establishes KIF21A as the CFEOM1 gene in 44 of 45 probands.
- reference: PMID:16365788
reference_title: "Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All affected members had a heterozygous mutation of the KIF21A gene in
exon 21 (R954W).
explanation: >-
Documents the recurrent exon 21 p.R954W allele shared across unrelated
families.
notes: >-
The same KIF21A alleles also cause the CFEOM3B pattern, so KIF21A genotype
does not map one-to-one onto the CFEOM1/CFEOM3 clinical classification.
- name: PHOX2A
association: Causative
relationship_type: CAUSATIVE
variant_origin: GERMLINE
subtype: CFEOM2
gene_term:
preferred_term: PHOX2A (ARIX; nIII/nIV homeodomain transcription factor)
term:
id: hgnc:691
label: PHOX2A
variants:
- name: PHOX2A c.439C>T (p.Gln90Ter)
gene:
preferred_term: PHOX2A
term:
id: hgnc:691
label: PHOX2A
type: nonsense variant
description: >-
Homozygous nonsense allele truncating PHOX2A at the start of the
homeodomain, reported in an Iranian CFEOM2 family. It joins the
splice-disrupting and brachyury-like-domain missense alleles of the
original CFEOM2 pedigrees as a loss-of-function change.
evidence:
- reference: PMID:14597037
reference_title: "A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 439C-->T mutation in this family changes a glutamine to a stop codon
(Q90X) at the beginning of the PHOX2A homeodomain region.
explanation: >-
Specifies the nonsense allele and its position at the homeodomain.
evidence:
- reference: PMID:11600883
reference_title: "Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Two of the mutations are predicted to disrupt splicing, whereas the third
alters an amino acid within the conserved brachyury-like domain.
explanation: >-
Characterises the loss-of-function nature of the CFEOM2 PHOX2A alleles.
- reference: PMID:14597037
reference_title: "A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It confirms PHOX2A as the autosomal recessive CFEOM2 disease gene and
provides evidence that the phenotypic differences between PHOX2A mutations
in man and mouse do not result from hypomorphic PHOX2A alleles in humans.
explanation: >-
Confirms PHOX2A as the recessive CFEOM2 gene through a nonsense allele.
- name: TUBB3
association: Causative
relationship_type: CAUSATIVE
variant_origin: GERMLINE
subtype: CFEOM3A
gene_term:
preferred_term: TUBB3 (neuron-specific beta-tubulin isotype III)
term:
id: hgnc:20772
label: TUBB3
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We report that eight heterozygous missense mutations in TUBB3, encoding
the neuron-specific beta-tubulin isotype III, result in a spectrum of
human nervous system disorders that we now call the TUBB3 syndromes.
explanation: >-
Establishes heterozygous TUBB3 missense variants as the cause of CFEOM3
and the wider TUBB3 syndromes.
notes: >-
Heterozygous missense variants are distributed across the tubulin fold. All
reported alleles alter microtubule dynamic instability, and a subset
additionally disrupts the microtubule-kinesin interface; that subset
distinction tracks with whether extraocular neurological features accompany
the CFEOM3. The broader TUBB3 syndrome spectrum, including the cortical
malformation arm that is not part of CFEOM, is curated separately in the
TUBB3-related Tubulinopathy entry.
- name: TUBB2B
association: Causative
relationship_type: CAUSATIVE
variant_origin: GERMLINE
gene_term:
preferred_term: TUBB2B (neuronal beta-tubulin isotype IIb)
term:
id: hgnc:30829
label: TUBB2B
variants:
- name: TUBB2B p.Glu421Lys
gene:
preferred_term: TUBB2B
term:
id: hgnc:30829
label: TUBB2B
type: missense variant
description: >-
An inherited heterozygous substitution altering a kinesin-binding site. It
behaves differently from the other TUBB2B alleles, which cause
polymicrogyria without primary axon dysinnervation.
evidence:
- reference: PMID:23001566
reference_title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Interestingly, by incorporating into microtubules and altering their
dynamic properties, the E421K substitution behaves differently than
previously identified TUBB2B substitutions, providing mechanistic
insight into the divergence between resulting phenotypes.
explanation: >-
Distinguishes the CFEOM-causing E421K allele from other TUBB2B
substitutions.
evidence:
- reference: PMID:23001566
reference_title: "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We have identified a novel inherited heterozygous missense mutation in
TUBB2B that results in an E421K amino acid substitution in a family who
segregates congenital fibrosis of the extraocular muscles (CFEOM) with
polymicrogyria.
explanation: >-
Identifies the single TUBB2B allele that causes CFEOM rather than isolated
polymicrogyria.
- name: COL25A1
association: Causative
relationship_type: CAUSATIVE
variant_origin: GERMLINE
subtype: CFEOM5
gene_term:
preferred_term: COL25A1 (CLAC-P neuronal transmembrane collagen)
term:
id: hgnc:18603
label: COL25A1
evidence:
- reference: PMID:25500261
reference_title: "Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
By using linkage analysis, candidate gene screening, and exome
sequencing, we identified three mutations in collagen, type XXV, alpha 1
(COL25A1) in individuals with autosomal-recessive inheritance of CCDD
ophthalmic phenotypes.
explanation: >-
Establishes biallelic COL25A1 variants as a cause of recessive CCDD with a
CFEOM phenotype.
notes: >-
The reported biallelic alleles reduce either the stability or the level of
the COL25A1 protein.
diagnosis:
- name: High-resolution orbital MRI
description: >-
Thin-section orbital MRI demonstrates hypoplasia of the affected extraocular
muscles together with hypoplasia and misdirection of the motor nerves that
supply them. This is the modality that established the neurogenic basis of
CFEOM, and so is the imaging counterpart of the causal direction this entry
models: the nerve lesion is visible alongside the muscle lesion it causes.
diagnosis_term:
preferred_term: magnetic resonance imaging
term:
id: NCIT:C16809
label: Magnetic Resonance Imaging
evidence:
- reference: PMID:34081534
reference_title: "Axonal Growth Abnormalities Underlying Ocular Cranial Nerve Disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "MRI of fourteen individuals with CFEOM1 and KIF21A mutations from six families demonstrated profound hypoplasia of the SR and LPS muscles, and hypoplasia and misdirection of all the motor nerves in the orbit"
explanation: >-
Establishes orbital MRI as the investigation that shows both the muscle
hypoplasia and the nerve hypoplasia and misdirection underlying it.
- name: Brain MRI for associated central malformations
description: >-
Brain imaging identifies the central nervous system malformations that
accompany the tubulinopathy forms, and so contributes to distinguishing
CFEOM3 from the more restricted CFEOM1 phenotype.
diagnosis_term:
preferred_term: magnetic resonance imaging
term:
id: NCIT:C16809
label: Magnetic Resonance Imaging
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Neuroimaging reveals a spectrum of abnormalities including hypoplasia of oculomotor nerves and dysgenesis of the corpus callosum, anterior commissure, and corticospinal tracts"
explanation: >-
Names the central malformations neuroimaging detects in the TUBB3 forms,
which is what makes brain imaging diagnostically informative here.
- name: Exome or genome sequencing
description: >-
Molecular diagnosis rests on sequencing the known CFEOM genes; broader exome
or genome sequencing is used for the substantial fraction of ocular
congenital cranial dysinnervation disorders that remain genetically
unsolved after targeted testing.
diagnosis_term:
preferred_term: genetic testing
term:
id: NCIT:C15709
label: Genetic Testing
evidence:
- reference: PMID:39033378
reference_title: "Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We coupled phenotyping with exome or genome sequencing of 467 probands"
explanation: >-
Documents exome or genome sequencing as the strategy applied to
genetically unsolved ocular CCDD probands, the group CFEOM sits within.
treatments:
- name: Inferior Rectus Recession (Strabismus Surgery)
description: >-
Bilateral recession of the tight, fibrotic inferior recti to raise the eyes
towards the horizontal midline and relieve the compensatory chin-up head
posture. Surgery rebalances the globes mechanically; it does not restore
innervation or ocular motility. A secondary exotropia, often A-pattern,
emerges after inferior rectus recession because adduction is further
weakened, so horizontal surgery is deliberately staged until the vertical
result has declared itself.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: strabismus surgery
term:
id: NCIT:C15331
label: Ophthalmologic Surgical Procedure
target_mechanisms:
- target: Denervation-Driven Extraocular Muscle Maldevelopment and Fibrosis
treatment_effect: MODULATES
description: >-
Recession lengthens the restrictive fibrotic muscle and so relieves the
mechanical tether, without addressing the upstream dysinnervation.
evidence:
- reference: PMID:31848785
reference_title: "Surgical management of pediatric patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Bilateral IR recession in pediatric patients with CFEOM was effective in
improving AHP, but postoperative exotropia appeared to be inevitable
owing to the diminished adducted function caused by IR recession.
explanation: >-
Documents both the benefit on head posture and the mechanical trade-off
of recessing the fibrotic muscle.
evidence:
- reference: PMID:31848785
reference_title: "Surgical management of pediatric patients with congenital fibrosis of the extraocular muscles."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Thus, horizontal strabismus surgery should be planned after the results of
IR recession become evident.
explanation: >-
Supports the staged surgical strategy recorded in this treatment entry.
- reference: PMID:31313749
reference_title: "Congenital fibrosis of the extraocular muscles: review of recent literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Surgical management of patients with CFEOM continues to be challenging.
explanation: >-
A contemporary review qualifies the expected benefit of strabismus surgery
in CFEOM.
- name: Frontalis Suspension for Ptosis
description: >-
Suspension of the eyelid to the frontalis muscle, typically with a silicone
sling, to lift the ptotic lid when levator function is too poor for levator
surgery. Lid elevation must be judged against the risk of exposure
keratopathy, since the immobile, infraducted globe and absent Bell phenomenon
leave the cornea vulnerable once the lid is raised.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: frontalis suspension ptosis surgery
term:
id: NCIT:C15331
label: Ophthalmologic Surgical Procedure
target_mechanisms:
- target: Bilateral Congenital Ptosis
treatment_effect: BYPASSES
description: >-
The sling substitutes frontalis action for the denervated levator
palpebrae superioris, mechanically bypassing rather than correcting the
dysinnervation.
evidence:
- reference: PMID:37364855
reference_title: "Outcome of silicone sling frontalis suspension in children with simple congenital and complex ptosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Complex cases included blepharophimosis epicanthus inversus syndrome (n
= 35), Marcus Gunn jaw-winking syndrome (n = 12), oculomotor palsy (n =
8), congenital fibrosis of extraocular muscles (n = 3), chronic
progressive external ophthalmoplegia (n = 3), and others.
explanation: >-
Places CFEOM among the complex ptosis indications treated by silicone
sling frontalis suspension in this cohort.
evidence:
- reference: PMID:37364855
reference_title: "Outcome of silicone sling frontalis suspension in children with simple congenital and complex ptosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Silicone sling FS has a favourable outcome in 70% of pediatric patients.
explanation: >-
Quantifies the expected outcome of the procedure in the paediatric
population that includes CFEOM.
- name: Amblyopia and Refractive Management
description: >-
Spectacle correction of refractive error together with occlusion or
penalization of the better-seeing eye. Because the motility deficit is
static and surgically irreversible, protecting visual development is the
part of management with the greatest effect on final acuity.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: refractive correction and amblyopia therapy
term:
id: NCIT:C15747
label: Supportive Care
target_mechanisms:
- target: Amblyopia
treatment_effect: MODULATES
description: >-
Correcting refractive error and forcing use of the amblyopic eye addresses
the deprivational and refractive contributions to visual loss, which are
independent of the dysinnervation itself.
evidence:
- reference: PMID:7724178
reference_title: "Congenital fibrosis of the vertically acting extraocular muscles. A new group of dominantly inherited ocular fibrosis with radiologic findings."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Refractive error and amblyopia also were variable.
explanation: >-
Establishes refractive error and amblyopia as variable, and therefore
individually assessable and treatable, features.
- name: Genetic Counseling
description: >-
Molecular testing distinguishes the autosomal dominant KIF21A, TUBB3, and
TUBB2B subtypes from the autosomal recessive PHOX2A and COL25A1 subtypes,
which carry very different recurrence risks, and identifies the TUBB3 and
TUBB2B genotypes that warrant surveillance for the extraocular neurological
features.
therapeutic_modality: OTHER
treatment_term:
preferred_term: genetic counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:20074521
reference_title: "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Each mutation causes the ocular motility disorder CFEOM3, whereas some
also result in intellectual and behavioral impairments, facial paralysis,
and/or later-onset axonal sensorimotor polyneuropathy.
explanation: >-
Allele-dependent extraocular features are the reason genotype changes
counselling and surveillance in CFEOM.
discussions:
- discussion_id: gap_cfeom_selective_oculomotor_vulnerability
prompt: >-
Why do ubiquitously expressed lesions in KIF21A, TUBB3, TUBB2B, and COL25A1
produce a phenotype largely restricted to the oculomotor and trochlear
nerves rather than a generalised axonopathy?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#KIF21A Kinesin Autoinhibition Loss
- pathophysiology#Beta-Tubulin Microtubule Dysfunction in Cranial Motor Neurons
- pathophysiology#Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
rationale: >-
KIF21A and the beta-tubulins are expressed far more widely than the ocular
motor nuclei, yet CFEOM1 is a clinically isolated eye movement disorder. The
mouse work names this as a selective vulnerability of the developing
oculomotor nerve to cytoskeletal perturbation but does not explain what
confers it, and the TUBB3 alleles that do add extraocular features show the
restriction is allele-dependent rather than absolute. Without a mechanism
for the selectivity, genotype-phenotype prediction across the spectrum
remains descriptive.
evidence:
- reference: PMID:24656932
reference_title: "Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
highlights a selective vulnerability of the developing oculomotor nerve to
perturbations of the axon cytoskeleton
explanation: >-
Names the selective vulnerability that this gap asks to be explained.
- reference: PMID:34081534
reference_title: "Axonal Growth Abnormalities Underlying Ocular Cranial Nerve Disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Study of these disorders highlights the complexities of axon guidance and
how each population of neurons uses a unique but overlapping set of axon
guidance pathways.
explanation: >-
Frames the population-specific guidance repertoire that a mechanism for
the selectivity would have to explain.
proposed_experiments:
- experiment_id: exp_cfeom_ocular_motor_neuron_specific_profiling
name: Developmental-stage profiling of ocular motor versus spinal motor neurons
description: >-
Compare the transcriptome, cytoskeletal composition, and kinesin cargo
complement of developing oculomotor, trochlear, abducens, and spinal motor
neurons at the stage at which CFEOM axons stall, in wild-type and in
Kif21a and Tubb3 knockin animals, to identify features that distinguish
the vulnerable from the spared pools.
decision_criterion: >-
Identification of a factor whose loss or supplementation shifts the
stalling phenotype between ocular motor and spared motor neuron
populations.
would_support:
- pathophysiology#Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
- discussion_id: gap_cfeom_mondo_myopathy_classification
prompt: >-
Should CFEOM continue to be classified ontologically as a myopathy of
extraocular muscle and a progressive muscular dystrophy when the evidence
establishes it as a non-progressive neurogenic dysinnervation disorder?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Hypoplasia of the Oculomotor and Trochlear Nerves
- pathophysiology#Denervation-Driven Extraocular Muscle Maldevelopment and Fibrosis
rationale: >-
MONDO:0007614 is currently placed under both myopathy of extraocular muscle
and progressive muscular dystrophy. Human neuropathology and genotyped
orbital MRI both establish that the neuronal lesion is primary and the
myopathy secondary, and every characterisation of the disorder describes it
as non-progressive. The ontology placement therefore asserts two things the
curated mechanism contradicts. This entry records the discrepancy rather
than silently reclassifying; resolving it belongs upstream in MONDO.
evidence:
- reference: PMID:15671279
reference_title: "Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
These findings suggest that neuronal disease is primary in CFEOM1, with
myopathy arising secondary to abnormal innervation and minimal rectus
pulley abnormality secondary to reduced EOM forces.
explanation: >-
States the primary-neurogenic, secondary-myopathic ordering that conflicts
with a myopathy or dystrophy classification.
- discussion_id: gap_cfeom_genetically_unsolved_probands
prompt: >-
What accounts for the majority of CFEOM and related ocular congenital
cranial dysinnervation disorder probands who remain genetically unsolved
after exome and genome sequencing?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
- pathophysiology#Hypoplasia of the Oculomotor and Trochlear Nerves
rationale: >-
The named CFEOM subtypes account for only part of the clinical spectrum.
A large sequencing study of previously unsolved ocular CCDD pedigrees
resolved fewer than one in ten probands and left most of the cohort without
a pathogenic variant, so the curated gene list here is a floor rather than a
complete account of the disorder. The locus-defined CFEOM3C subtype and the
unmapped Tukel syndrome gene are the same gap visible from the nosological
side.
evidence:
- reference: PMID:39033378
reference_title: "Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Analyses elucidated phenotypic subgroups, identified pathogenic/likely
pathogenic variant(s) in 43 of 467 probands (9.2%), and prioritized
variants of uncertain significance in 70 of 467 additional probands
(15.0%).
explanation: >-
Quantifies how much of the previously unsolved ocular CCDD cohort remains
without an established genetic cause.
- reference: PMID:39033378
reference_title: "Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This study suggests that unsolved oCCDDs are clinically and genetically
heterogeneous disorders often overlapping other Mendelian conditions and
nominates many candidates for future replication and functional studies.
explanation: >-
States that the residual cohort is heterogeneous and overlaps other
Mendelian conditions, which is why the gap is not closed by one gene.
proposed_experiments:
- experiment_id: exp_cfeom_noncoding_and_functional_replication
name: Non-coding and functional replication of prioritized oCCDD candidates
description: >-
Extend sequencing of unsolved CFEOM pedigrees beyond protein-coding
regions to regulatory and structural variation affecting the established
axon-guidance genes, and functionally test prioritized candidate variants
in ocular motor neuron models for the stalling and misrouting phenotype.
decision_criterion: >-
Replication of a candidate gene or regulatory variant in independent
pedigrees together with a reproducible ocular motor axon phenotype in a
model system.
would_support:
- pathophysiology#Oculomotor Axon Stalling and Aberrant Growth Cone Guidance
datasets: []
Congenital fibrosis of the extraocular muscles (CFEOM) is a genetically heterogeneous congenital cranial dysinnervation disorder (CCDD). Despite its historical name, it is primarily a developmental neurologic disorder: abnormal specification or axon growth/guidance of ocular motor neurons produces deficient or aberrant innervation, followed secondarily by extraocular-muscle hypoplasia, contracture, and fibrosis. The defining manifestations are congenital, usually nonprogressive restrictive ophthalmoplegia, strabismus, and frequently ptosis. CFEOM1 is most often caused by dominant KIF21A variants, CFEOM2 by biallelic PHOX2A loss-of-function variants, and CFEOM3 by dominant TUBB3 variants; rarer CFEOM-like phenotypes involve TUBA1A and TUBB2B. Mechanisms converge on motor-neuron specification, neuronal microtubule dynamics, kinesin–microtubule interactions, and cranial-axon pathfinding. (fritzsch2023evolutionanddevelopment pages 16-18, whitman2021axonalgrowthabnormalities pages 6-8, puri2023tubb3andkif21a pages 20-21)
There is no disease-modifying pharmacotherapy. Current care consists of amblyopia prevention, refractive correction, ocular-surface protection, and individualized strabismus and ptosis surgery. Population prevalence, health-related quality-of-life scores, long-term prospective outcomes, and controlled treatment-response rates remain poorly characterized.
CFEOM is a Mendelian CCDD characterized by congenital restriction of eye movements, generally accompanied by incomitant strabismus and ptosis. Human autopsy, MRI, and model-organism data shifted the accepted interpretation from a primary extraocular-muscle disease to primary developmental dysinnervation with secondary muscle fibrosis. In genetically confirmed CFEOM1, human pathology showed absence of the superior division of cranial nerve III (CN III) and corresponding motor neurons; MRI showed profound hypoplasia of the superior rectus and levator palpebrae superioris and abnormalities of ocular motor nerves. (whitman2021axonalgrowthabnormalities pages 6-8)
Common names: congenital fibrosis of the extraocular muscles; CFEOM; congenital external ophthalmoplegia; congenital restrictive ophthalmoplegia; generalized fibrosis syndrome; congenital ophthalmoplegia; and, historically, congenital fibrosis syndrome. “CFEOM” should be preferred because congenital external ophthalmoplegia has broader differential diagnoses.
Disease-level versus patient-level evidence: This report synthesizes aggregated disease-level resources, cohorts, pedigrees, case series, neuroimaging, animal models, and biochemical experiments. It does not contain identifiable EHR-derived patient data. The 2022 Chinese study, for example, aggregated 122 affected individuals from 96 families, while the recent large oCCDD genomics study analyzed 467 unsolved pedigrees. (jia2022clinicalandgenetic pages 13-14, jurgens2025expandingthegenetics pages 38-41)
Identifiers should be represented at both umbrella and subtype levels because CFEOM is genetically heterogeneous.
The following table provides the core genotype–phenotype structure.
| Subtype / OMIM status | Principal gene | Inheritance | Hallmark ocular phenotype | Associated / systemic findings | Principal developmental mechanism |
|---|---|---|---|---|---|
| CFEOM1 / OMIM not asserted here | KIF21A | Autosomal dominant; often familial, can be de novo | Congenital bilateral ptosis; eyes typically fixed infraducted; severe limitation of upgaze with variable horizontal restriction | Usually isolated ocular phenotype, though syndromic presentations are reported in some variant contexts; MRI/human pathology show hypoplastic superior rectus and levator with oculomotor nerve abnormalities (whitman2021axonalgrowthabnormalities pages 6-8, fritzsch2023evolutionanddevelopment pages 14-16) | Gain-of-function/missense mechanism that reduces KIF21A autoinhibition, alters kinesin-microtubule behavior, and stalls superior-division CN III axon growth/guidance during development (whitman2021axonalgrowthabnormalities pages 6-8, puri2023tubb3andkif21a pages 20-21) |
| CFEOM2 / OMIM not asserted here | PHOX2A | Autosomal recessive | Congenital bilateral ptosis with exotropia at rest and profound restriction of ocular movements | MRI evidence of absent oculomotor and trochlear nerves; may be accompanied by pupil abnormalities in classic descriptions; generally a cranial motor neuron specification disorder (fritzsch2023evolutionanddevelopment pages 16-18) | Loss of PHOX2A function disrupts specification/development of oculomotor and trochlear motor neuron nuclei, causing failure of normal innervation to extraocular muscles (fritzsch2023evolutionanddevelopment pages 16-18) |
| CFEOM3 / OMIM not asserted here | TUBB3 | Autosomal dominant; variable expressivity, including de novo cases | Variable congenital ophthalmoplegia, often asymmetric; ptosis may be unilateral or bilateral; limited upgaze common, horizontal deficits variable | Can be isolated or syndromic; reported associations include additional cranial/peripheral neuropathy features and white-matter/brain abnormalities depending on variant (fritzsch2023evolutionanddevelopment pages 16-18, jia2022clinicalandgenetic pages 13-14) | Missense variants in neuronal β-tubulin III alter microtubule dynamics and kinesin interaction, impairing cranial axon growth, maintenance, and guidance (fritzsch2023evolutionanddevelopment pages 16-18, puri2023tubb3andkif21a pages 20-21) |
| Rare CFEOM-associated phenotype / OMIM not asserted here | TUBA1A | Typically autosomal dominant / de novo in reported cases | CFEOM phenotype with congenital ophthalmoplegia/ptosis | May occur with or without malformations of cortical development; broader tubulinopathy features can be present (jia2022clinicalandgenetic pages 13-14) | Altered α-tubulin function perturbs neuronal microtubules, cranial axon guidance, and in some cases cortical development (jia2022clinicalandgenetic pages 13-14) |
| Rare CFEOM-associated phenotype / OMIM not asserted here | TUBB2B | Typically autosomal dominant in reported families | CFEOM/ophthalmoplegia phenotype | Can be associated with polymicrogyria and broader axon dysinnervation syndrome rather than isolated CFEOM (jia2022clinicalandgenetic pages 13-14) | Altered β-tubulin/kinesin-binding interface disrupts axon guidance and brain development (jia2022clinicalandgenetic pages 13-14) |
Table: This table summarizes the main genetically defined CFEOM subtypes and rarer tubulin-associated presentations, highlighting inheritance, distinguishing ocular findings, systemic associations, and developmental mechanisms. It is useful as a compact knowledge-base scaffold when exact identifiers are uncertain or subtype boundaries overlap.
The principal cause is a germline pathogenic variant affecting ocular motor-neuron development:
A pathogenic familial allele, an affected parent, and consanguinity in recessive PHOX2A disease are the clinically relevant risk factors. Dominant cases may also arise de novo. Variable expressivity is particularly important in TUBB3-related and some KIF21A-related disease; absence of severe ophthalmoplegia in a parent does not automatically exclude familial transmission. (fritzsch2023evolutionanddevelopment pages 16-18, fritzsch2023evolutionanddevelopment pages 14-16)
A common allele is not evidence of causality: the KIF21A 3′-UTR deletion c.690del has a reported gnomAD allele frequency of 0.1377*, including 156 homozygotes, and is therefore incompatible with being a highly penetrant cause of rare dominant CFEOM. The frameshift c.4602_4606del, p.(Thr1535GlnfsTer3), was reported as a VUS rather than an established pathogenic allele. (puri2023tubb3andkif21a pages 20-21)
No reproducible toxin, infection, radiation exposure, diet, smoking behavior, occupation, or other environmental exposure is established as a cause or modifier of genetically defined CFEOM. No validated protective allele, diet, medication, or lifestyle intervention prevents the developmental dysinnervation. Accordingly, conventional gene–environment interaction models are not currently supported. These are evidence gaps, not proof that modifiers cannot exist.
| Phenotype | Type and suggested HPO term | Onset/course | Typical pattern and impact |
|---|---|---|---|
| Restrictive ophthalmoplegia | Sign: Ophthalmoplegia, HP:0000602; limitation of extraocular movement | Congenital; chronic and usually nonprogressive | Vertical restriction is prominent; horizontal restriction varies. Limits visual-field access and drives compensatory head posture. |
| Ptosis | Sign: Blepharoptosis, HP:0000508 | Congenital; stable, severity variable | Usually bilateral in CFEOM1/2; may be asymmetric in CFEOM3. Severe ptosis can obstruct the visual axis and contribute to amblyopia. |
| Strabismus | Sign: Strabismus, HP:0000486 | Congenital; persistent | CFEOM1 commonly has infraducted eyes; CFEOM2 typically exotropia; CFEOM3 is variable/asymmetric. |
| Absent or limited upgaze | Sign: limitation of upward gaze; map to the most specific current HPO ocular-motility term | Congenital; stable | Characteristic of CFEOM1 and frequent in CFEOM3. |
| Abnormal head posture | Physical manifestation: Abnormal head posture, HP:0002186 | Early childhood onward | Chin elevation or face turn compensates for restricted primary gaze; may impair mobility and cause musculoskeletal discomfort. |
| Amblyopia/reduced acuity | Complication: Amblyopia, HP:0000646; Reduced visual acuity, HP:0007663 | Develops during childhood visual maturation | Related to ptosis, anisometropia, or strabismus; potentially preventable with early ophthalmic care. |
| Refractive error | Clinical sign: Abnormality of refraction, HP:0000539 | Childhood | Requires cycloplegic refraction and correction. |
| Pupil abnormality | Sign: Abnormality of the pupil, HP:0000615 | Congenital | Particularly relevant in PHOX2A/CFEOM2 and selected TUBB3 phenotypes. |
CFEOM1 classically presents with bilateral ptosis, eyes fixed below the horizontal midline, absent vertical movement, and variably limited horizontal movement. CFEOM2 combines bilateral ptosis, exotropia, severe movement restriction, and absent CN III/CN IV on MRI. CFEOM3 is more variable and often asymmetric, with variable ptosis and limited upgaze. (fritzsch2023evolutionanddevelopment pages 16-18, fritzsch2023evolutionanddevelopment pages 14-16)
Variant-specific TUBB3 disease may add facial weakness, additional cranial neuropathies, peripheral neuropathy, developmental delay, intellectual disability, corpus-callosal or white-matter abnormalities, and other brain malformations. TUBA1A/TUBB2B disease can include cortical malformations. These findings are not obligatory in classic isolated CFEOM and should trigger broader neurologic evaluation. (fritzsch2023evolutionanddevelopment pages 16-18, jia2022clinicalandgenetic pages 13-14)
In the 2022 Chinese CCDD cohort, 46/96 families (47.9%) had multiple congenital malformations. Among 88 families with high-resolution MRI, 15/88 (17.0%) had additional craniocerebral malformations. These percentages concern a mixed CCDD cohort and must not be presented as CFEOM-specific population frequencies. (jia2022clinicalandgenetic pages 13-14)
No robust CFEOM-specific EQ-5D, SF-36, PROMIS, or utility-weight dataset was found. Likely burdens include restricted field of binocular single vision, abnormal head posture, cosmetic/social effects of ptosis and strabismus, repeated surgery, amblyopia risk, and—where syndromic—neurologic disability. These impacts are clinically credible but lack disease-specific population estimates.
All established CFEOM variants are germline. Somatic mosaicism is not a recognized principal mechanism, although low-level parental germline or somatic mosaicism may theoretically explain recurrence after an apparently de novo case. Population databases should be checked using the exact transcript and genome build; highly penetrant causal alleles are expected to be absent or exceptionally rare.
In the 2022 Chinese cohort, WES identified ten pathogenic variants in KIF21A, TUBB3, and CHN1 across 43 families; 42 of the 43 genetically solved probands had CFEOM. Novel reported variants included KIF21A c.1064T>C, p.Phe355Ser; TUBB3 c.232T>A, p.Ser78Thr; and CHN1 c.650A>G, p.His217Arg. The authors concluded that “KIF21A and TUBB3 were the common pathogenic genes in Chinese CFEOM” and that MRI plus WES supported diagnosis. (jia2022clinicalandgenetic pages 13-14)
A later analysis of 467 previously unsolved oCCDD pedigrees, including 198 CFEOM probands, found pathogenic/likely pathogenic variants in 43/467 (9.2%) and prioritized VUS in another 70/467 (15.0%). Candidate findings extended beyond established genes to MYH10, KIF21B, TUBB6, TUBA4A, KIF5C, and others, but these newer gene associations require independent replication and functional validation before routine designation as definitive CFEOM genes. (jurgens2025expandingthegenetics pages 8-12, jurgens2025expandingthegenetics pages 38-41)
No replicated CFEOM modifier gene or disease-specific epigenetic signature is established. Structural variants and chromosomal disruptions can produce oCCDD phenocopies or syndromic disease, so genome sequencing or chromosomal microarray is appropriate in unresolved syndromic cases. The recent 467-pedigree study explicitly integrated structural-variant analysis and found extensive heterogeneity. (jurgens2025expandingthegenetics pages 8-12, jurgens2025expandingthegenetics pages 38-41)
CFEOM is not known to be infectious, toxic, occupational, nutritional, radiation-induced, inflammatory, or lifestyle-mediated. Smoking, alcohol, diet, and exercise do not have established effects on disease occurrence. Environmental interventions cannot reverse embryonic cranial dysinnervation, although ordinary eye safety, ocular-surface care, and adherence to amblyopia treatment can reduce secondary morbidity.
KIF21A is an anterograde kinesin. Normally, interaction between the motor domain and the third coiled-coil stalk domain maintains a closed, autoinhibited state. CFEOM-associated missense variants attenuate this autoinhibition, increase microtubule association, and dysregulate cortical microtubule growth. In knock-in mice, superior-division CN III axons stall proximally in bulb-like enlargements containing abnormal growth cones and degenerating axons; distal nerve and target muscles are hypoplastic. (whitman2021axonalgrowthabnormalities pages 6-8, puri2023tubb3andkif21a pages 20-21)
PHOX2A is a transcription factor required for development/specification of oculomotor and trochlear motor neurons. Loss of function prevents proper formation of these nuclei, explaining the MRI absence of CN III and CN IV and the profound CFEOM2 phenotype. (fritzsch2023evolutionanddevelopment pages 16-18)
TUBB3 encodes neuron-enriched βIII-tubulin. Pathogenic missense variants alter microtubule behavior and interactions with kinesin motors, producing variant-specific errors in cranial axon growth, guidance, maintenance, and—in some alleles—cortical neuronal migration. This explains the continuum from isolated CFEOM3 to multisystem tubulinopathy. (fritzsch2023evolutionanddevelopment pages 16-18, puri2023tubb3andkif21a pages 20-21)
There is no established primary metabolic, immune, inflammatory, apoptotic, or oxidative-stress pathway. The “fibrosis” is downstream of dysinnervation rather than evidence of a systemic fibrosing disorder.
No validated diagnostic transcriptomic, proteomic, metabolomic, lipidomic, single-cell, spatial-transcriptomic, or multi-omic CFEOM signature was found. Current molecular evidence is dominated by pedigree sequencing, structural/biochemical assays, neuroimaging, and engineered animal models. The large recent genomics study demonstrates the value of combined exome/genome and structural-variant analysis but also shows that most previously unsolved pedigrees remain without a definitive molecular diagnosis. (jurgens2025expandingthegenetics pages 8-12, jurgens2025expandingthegenetics pages 38-41)
Primary nervous-system structures: oculomotor nucleus and nerve (CN III), especially its superior division in KIF21A-CFEOM1; trochlear nucleus/nerve (CN IV), particularly in PHOX2A disease; and variably abducens pathways (CN VI). The midbrain and rostral hindbrain are the critical developmental regions.
Primary orbital structures: superior, inferior, medial, and lateral rectus; superior and inferior oblique; and levator palpebrae superioris. In KIF21A-CFEOM1, superior rectus and levator hypoplasia are especially prominent. Human MRI of 14 genetically affected individuals from six families demonstrated muscle hypoplasia and motor-nerve abnormalities. (whitman2021axonalgrowthabnormalities pages 6-8)
Secondary structures: eyelids, visual pathways affected by amblyopia, and—depending on genotype—corpus callosum, cerebral white matter, cortex, basal ganglia, additional cranial nerves, and peripheral nerves.
Suggested UBERON terms: eye (UBERON:0000970); extraocular muscle (use the current specific UBERON EOM record); oculomotor nerve (UBERON:0001643); trochlear nerve; abducens nerve; midbrain (UBERON:0001891); hindbrain (UBERON:0002028); upper eyelid; superior rectus muscle; levator palpebrae superioris.
Disease is typically bilateral in CFEOM1/2, whereas CFEOM3 may be unilateral, bilateral, or markedly asymmetric. (fritzsch2023evolutionanddevelopment pages 16-18)
The initiating defect occurs during embryonic ocular motor-neuron development. Clinical signs are present at birth or recognized in early infancy. The dysinnervation is nonprogressive, but secondary consequences evolve: amblyopia develops during the sensitive period of visual maturation; abnormal head posture and contractures may become more apparent with growth; and surgical alignment can drift or require revision. There are no defined early/intermediate/end-stage categories, remissions, or relapsing episodes.
The principal intervention window is early childhood: clear the visual axis, correct refractive error, treat amblyopia, and establish the most functional head position possible. The underlying nerve-development defect does not spontaneously recover.
Anticipation is not established. Penetrance is often high for classic KIF21A-CFEOM1 but is variant- and family-dependent; expressivity is particularly variable in CFEOM3. Germline mosaicism should be discussed after an apparently de novo result because recurrence risk is low but not zero.
CFEOM is very rare, but no reliable population-based prevalence, incidence, carrier-frequency, sex-ratio, mortality, or geographic-distribution estimate was recovered. Published cohorts are referral- and ancestry-dependent and should not be used as population prevalence samples. The Chinese cohort demonstrates worldwide occurrence and genetic heterogeneity but does not establish higher risk in Chinese ancestry. (jia2022clinicalandgenetic pages 13-14)
No consistent sex bias is expected for autosomal disease. Founder effects may exist in individual PHOX2A families or populations, but no universal founder allele is established.
Diagnosis begins with congenital onset, nonprogressive restrictive motility, ptosis, globe position, forced-duction findings, and family history. Examination should include visual acuity appropriate for age, cycloplegic refraction, amblyopia assessment, pupil examination, ocular alignment in multiple gaze positions, head posture, eyelid function, Bell phenomenon, corneal exposure, fundus/optic-nerve examination, and complete neurologic/dysmorphology review.
Obtain thin-section, high-resolution MRI of the brainstem, cranial nerves, and orbits when feasible. MRI can identify absent/hypoplastic or misdirected ocular motor nerves, extraocular-muscle hypoplasia, and syndromic cerebral abnormalities. In one broad Chinese CCDD cohort, all MRI-assessed patients except those with horizontal-gaze-palsy/progressive-scoliosis had cranial-nerve hypoplasia; MRI plus WES was judged diagnostically supportive. (jia2022clinicalandgenetic pages 13-14)
Karyotyping/FISH are not first-line unless a specific rearrangement is suspected. Mitochondrial DNA and repeat-expansion testing are not routine CFEOM tests. RNA sequencing may help resolve splice variants but is not an established clinical standard. A VUS must not direct irreversible treatment or predictive testing without additional evidence.
Important alternatives include Duane retraction syndrome, Möbius syndrome, isolated congenital CN III/IV/VI palsy, congenital myasthenic syndrome, congenital myopathy, mitochondrial external ophthalmoplegia, MYF5-related external ophthalmoplegia with rib/vertebral anomalies, HOXA1/SALL4/ROBO3-related CCDD, orbital fibrosis, thyroid eye disease, congenital ptosis without ophthalmoplegia, and mechanical restrictive strabismus. Congenital stability, characteristic nerve/MRI anatomy, associated anomalies, and molecular testing distinguish these entities.
CFEOM is not included in routine newborn biochemical screening. Appropriate strategies are clinical newborn/infant eye examination in known families, cascade testing of relatives after identification of a pathogenic variant, and prenatal or preimplantation genetic testing when the familial variant is known.
CFEOM itself is not expected to shorten life in isolated disease; no disease-specific survival or mortality statistics exist. Morbidity is primarily visual and functional. Without timely care, ptosis, strabismus, and anisometropia can produce irreversible amblyopia. Persistent ophthalmoplegia and limited binocular visual fields remain lifelong even after successful alignment surgery.
Prognosis depends on genotype, baseline visual acuity, amblyopia, severity and symmetry of restriction, head posture, Bell phenomenon/corneal protection, and syndromic neurologic involvement. Surgery can improve primary-position alignment, head posture, eyelid position, and appearance, but does not restore normal innervation or full motility. Controlled long-term response rates and validated CFEOM-specific prognostic biomarkers are unavailable.
Suggested NCIt intervention mappings: strabismus surgery; extraocular-muscle recession; extraocular-muscle resection; tendon transposition; ptosis repair; frontalis suspension; amblyopia therapy; corrective-lens therapy. Exact NCIt codes should be validated against the current thesaurus release.
There is no approved CFEOM-specific drug, pharmacogenomic algorithm, gene therapy, cell therapy, ASO, siRNA, immune therapy, or CRISPR treatment. Experimental work showing correction of mutant tubulin–kinesin interaction in a mouse/biochemical system is mechanistic proof of principle, not a clinically available therapy. The broader mechanistic literature shows that altered TUBB3–kinesin interaction can be experimentally rescued, supporting future target discovery. (puri2023tubb3andkif21a pages 20-21)
A recruiting observational study, NCT03059420, “Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies,” is designed for genetic/phenotypic discovery rather than therapeutic efficacy: https://clinicaltrials.gov/study/NCT03059420.
Primary lifestyle or vaccine prevention is not applicable to a congenital Mendelian dysinnervation disorder. Reproductive prevention options include genetic counseling, carrier testing for relatives in PHOX2A families, cascade testing in dominant families, prenatal diagnosis, and preimplantation genetic testing for a known familial pathogenic variant.
Secondary prevention consists of early ophthalmologic detection and prevention of amblyopia or corneal exposure. Tertiary prevention includes optimized alignment/head posture, low-vision or educational support where necessary, and surveillance for neurologic complications in syndromic tubulinopathies. Population screening is not justified by current prevalence and intervention evidence.
No well-validated naturally occurring veterinary disease that is genetically and phenotypically equivalent to human CFEOM was identified. There is no zoonotic transmission or cross-species infectious susceptibility. The relevant genes and ocular motor-development programs are evolutionarily conserved across vertebrates, enabling engineered mouse and zebrafish studies; conservation should not be confused with naturally occurring animal disease.
Suggested taxonomy identifiers for experimental work include Mus musculus, NCBI Taxon 10090, and Danio rerio, NCBI Taxon 7955.
Knock-in mice carrying the orthologous human CFEOM1 mutation reproduce ptosis/globe retraction and selective superior-division CN III pathology. Axons form proximal bulbs with enlarged growth cones, stall, and degenerate; distal nerves and superior rectus/levator targets become hypoplastic. These models strongly recapitulate developmental dysinnervation but do not reproduce every aspect of human visual behavior or surgical disease. (whitman2021axonalgrowthabnormalities pages 6-8)
Loss-of-function models fail to specify or maintain oculomotor and trochlear motor-neuron populations, directly supporting the upstream transcription-factor mechanism of CFEOM2. (fritzsch2023evolutionanddevelopment pages 16-18)
TUBB3 knock-in mice and recombinant tubulin assays model variant-specific microtubule and kinesin defects. In vitro work shows that disease-associated substitutions can impair kinesin motility/ATPase function, while engineered compensatory kinesin changes can restore axonal growth in experimental systems. These are powerful mechanistic models but do not establish safety or feasibility of analogous human treatment. (puri2023tubb3andkif21a pages 20-21)
Zebrafish and other vertebrate systems are useful for rapid analysis of cranial-axon pathfinding and conserved ocular motor circuitry, but the best directly disease-relevant evidence presently comes from mouse knock-in and recombinant microtubule–motor assays.
The strongest evidence consists of human pedigrees, genotype–phenotype cohorts, MRI/pathology, knock-in mice, and in-vitro microtubule–kinesin assays. Major limitations are referral bias, small subtype-specific cohorts, inconsistent historical classification, lack of population registries, sparse standardized surgical outcomes, and virtually no disease-specific quality-of-life or prospective natural-history data. Candidate-gene findings from unsolved oCCDD cohorts must not be conflated with definitively validated CFEOM genes. No claim of environmental protection, pharmacologic efficacy, or advanced-omics biomarker is currently justified.
References
(fritzsch2023evolutionanddevelopment pages 16-18): Bernd Fritzsch. Evolution and development of extra-ocular nerves and muscles in vertebrates. Unknown journal, Jun 2023. URL: https://doi.org/10.20944/preprints202306.0416.v1, doi:10.20944/preprints202306.0416.v1.
(whitman2021axonalgrowthabnormalities pages 6-8): Mary C. Whitman. Axonal growth abnormalities underlying ocular cranial nerve disorders. Sep 2021. URL: https://doi.org/10.1146/annurev-vision-093019-114307, doi:10.1146/annurev-vision-093019-114307. This article has 22 citations and is from a peer-reviewed journal.
(puri2023tubb3andkif21a pages 20-21): Dharmendra Puri, Brenda J. Barry, and Elizabeth C. Engle. Tubb3 and kif21a in neurodevelopment and disease. Frontiers in Neuroscience, Aug 2023. URL: https://doi.org/10.3389/fnins.2023.1226181, doi:10.3389/fnins.2023.1226181. This article has 43 citations and is from a peer-reviewed journal.
(jia2022clinicalandgenetic pages 13-14): Hongyan Jia, Qian Ma, Yi Liang, Dan Wang, Qinglin Chang, Bo Zhao, Zongrui Zhang, Jing Liang, Jing Song, Yidi Wang, Ranran Zhang, Zhanhan Tu, and Yonghong Jiao. Clinical and genetic characteristics of chinese patients with congenital cranial dysinnervation disorders. Orphanet Journal of Rare Diseases, Dec 2022. URL: https://doi.org/10.1186/s13023-022-02582-5, doi:10.1186/s13023-022-02582-5. This article has 12 citations and is from a peer-reviewed journal.
(jurgens2025expandingthegenetics pages 38-41): Julie A. Jurgens, Brenda J. Barry, Wai-Man Chan, Sarah E. Mackinnon, M. Whitman, Paola M. Matos Ruiz, Brandon M Pratt, E. England, Lynn Pais, G. Lemire, E. Groopman, Carmen Glaze, Kathryn A Russell, M. Singer-Berk, Silvio Alessandro Di Gioia, Arthur S. Lee, Caroline Andrews, Sherin Shaaban, Megan M Wirth, Sarah Bekele, Melissa Toffoloni, Victoria R Bradford, Emma E. Foster, Lindsay Berube, Cristina Rivera-Quiles, Fiona M. Mensching, Alba Sanchis-Juan, Jack M. Fu, Isaac Wong, Xuefang Zhao, M. Wilson, B. Weisburd, M. Lek, Hugo Abarca-Barriga, C. Al-Haddad, Jeffrey Berman, E. Bothun, J. Capasso, O. Chacón-Camacho, Lan-Yun Chang, Stephen P Christiansen, M. Ciccarelli, M. Cordonnier, G. F. Cox, Cynthia J. Curry, L. Dagi, Thomas Lee Dahm, Karen David, B. Davitt, T. de Berardinis, J. Demer, J. Desir, F. D’Esposito, A. Drack, Eric Eggenberger, J. Elder, A. Elliott, K. Epley, H. Feldman, Carlos R. Ferreira, Maree P. Flaherty, A. B. Fulton, C. Gerth-Kahlert, I. Gottlob, Stephen Grill, D. Halliday, F. Hanisch, Eleanor Hay, G. Heidary, C. Holder, Jonathan C. Horton, A. Iannaccone, Sherwin J. Isenberg, S. Johnston, A. Kahana, J. Katowitz, M. Kazlas, Natalie C Kerr, Virginia E. Kimonis, M. Ko, Feray Koç, D. Larsen, G. Lay-Son, D. Ledoux, Alex V Levin, Richard Levy, Christopher J. Lyons, D. Mackey, Adriano Magli, Iason S. Mantagos, Candice Marti, I. Maystadt, Fiona McKenzie, Manoj P Menezes, Claudia N. Mikail, David T. Miller, K. B. Miller, M. Mills, K. Miyana, H. U. Møller, L. Mullineaux, J. Nishimura, A. Noble, P. K. Pandey, Piero Pavone, Johann Penzien, R. Petersen, James A. Phalen, A. Poduri, C. R. Polo, L. Prasov, F. Ramos, Maria Ramos-Cáceres, Richard M. Robb, Béatrice Rossillion, Mustafa Sahin, Harvey S Singer, Lois E. H. Smith, J. A. Sorkin, J. Soul, S. Staffieri, Heather Stalker, S. Stasheff, Sonya Strassberg, Mitchell B. Strominger, D. Taranath, Ioan T. Thomas, Elias I. Traboulsi, M. C. Ugrin, Deborah K. Vanderveen, Andrea L. Vincent, Marlene C. Vogel G, B. Wabbels, A. Wong, C. Woods, Carolyn Wu, Edward Yang, A. Yeung, Terri L. Young, J. Zenteno, Alexandra A. Zubcov-Iwantscheff, Johan Zwaan, Harrison Brand, M. Talkowski, D. MacArthur, A. O’Donnell-Luria, C. Robson, David G. Hunter, and Elizabeth C. Engle. Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders. Genetics in medicine : official journal of the American College of Medical Genetics, 27:101216-101216, Jul 2025. URL: https://doi.org/10.1016/j.gim.2024.101216, doi:10.1016/j.gim.2024.101216. This article has 20 citations.
(fritzsch2023evolutionanddevelopment pages 14-16): Bernd Fritzsch. Evolution and development of extra-ocular nerves and muscles in vertebrates. Unknown journal, Jun 2023. URL: https://doi.org/10.20944/preprints202306.0416.v1, doi:10.20944/preprints202306.0416.v1.
(jurgens2025expandingthegenetics pages 36-37): Julie A. Jurgens, Brenda J. Barry, Wai-Man Chan, Sarah E. Mackinnon, M. Whitman, Paola M. Matos Ruiz, Brandon M Pratt, E. England, Lynn Pais, G. Lemire, E. Groopman, Carmen Glaze, Kathryn A Russell, M. Singer-Berk, Silvio Alessandro Di Gioia, Arthur S. Lee, Caroline Andrews, Sherin Shaaban, Megan M Wirth, Sarah Bekele, Melissa Toffoloni, Victoria R Bradford, Emma E. Foster, Lindsay Berube, Cristina Rivera-Quiles, Fiona M. Mensching, Alba Sanchis-Juan, Jack M. Fu, Isaac Wong, Xuefang Zhao, M. Wilson, B. Weisburd, M. Lek, Hugo Abarca-Barriga, C. Al-Haddad, Jeffrey Berman, E. Bothun, J. Capasso, O. Chacón-Camacho, Lan-Yun Chang, Stephen P Christiansen, M. Ciccarelli, M. Cordonnier, G. F. Cox, Cynthia J. Curry, L. Dagi, Thomas Lee Dahm, Karen David, B. Davitt, T. de Berardinis, J. Demer, J. Desir, F. D’Esposito, A. Drack, Eric Eggenberger, J. Elder, A. Elliott, K. Epley, H. Feldman, Carlos R. Ferreira, Maree P. Flaherty, A. B. Fulton, C. Gerth-Kahlert, I. Gottlob, Stephen Grill, D. Halliday, F. Hanisch, Eleanor Hay, G. Heidary, C. Holder, Jonathan C. Horton, A. Iannaccone, Sherwin J. Isenberg, S. Johnston, A. Kahana, J. Katowitz, M. Kazlas, Natalie C Kerr, Virginia E. Kimonis, M. Ko, Feray Koç, D. Larsen, G. Lay-Son, D. Ledoux, Alex V Levin, Richard Levy, Christopher J. Lyons, D. Mackey, Adriano Magli, Iason S. Mantagos, Candice Marti, I. Maystadt, Fiona McKenzie, Manoj P Menezes, Claudia N. Mikail, David T. Miller, K. B. Miller, M. Mills, K. Miyana, H. U. Møller, L. Mullineaux, J. Nishimura, A. Noble, P. K. Pandey, Piero Pavone, Johann Penzien, R. Petersen, James A. Phalen, A. Poduri, C. R. Polo, L. Prasov, F. Ramos, Maria Ramos-Cáceres, Richard M. Robb, Béatrice Rossillion, Mustafa Sahin, Harvey S Singer, Lois E. H. Smith, J. A. Sorkin, J. Soul, S. Staffieri, Heather Stalker, S. Stasheff, Sonya Strassberg, Mitchell B. Strominger, D. Taranath, Ioan T. Thomas, Elias I. Traboulsi, M. C. Ugrin, Deborah K. Vanderveen, Andrea L. Vincent, Marlene C. Vogel G, B. Wabbels, A. Wong, C. Woods, Carolyn Wu, Edward Yang, A. Yeung, Terri L. Young, J. Zenteno, Alexandra A. Zubcov-Iwantscheff, Johan Zwaan, Harrison Brand, M. Talkowski, D. MacArthur, A. O’Donnell-Luria, C. Robson, David G. Hunter, and Elizabeth C. Engle. Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders. Genetics in medicine : official journal of the American College of Medical Genetics, 27:101216-101216, Jul 2025. URL: https://doi.org/10.1016/j.gim.2024.101216, doi:10.1016/j.gim.2024.101216. This article has 20 citations.
(jurgens2025expandingthegenetics pages 8-12): Julie A. Jurgens, Brenda J. Barry, Wai-Man Chan, Sarah E. Mackinnon, M. Whitman, Paola M. Matos Ruiz, Brandon M Pratt, E. England, Lynn Pais, G. Lemire, E. Groopman, Carmen Glaze, Kathryn A Russell, M. Singer-Berk, Silvio Alessandro Di Gioia, Arthur S. Lee, Caroline Andrews, Sherin Shaaban, Megan M Wirth, Sarah Bekele, Melissa Toffoloni, Victoria R Bradford, Emma E. Foster, Lindsay Berube, Cristina Rivera-Quiles, Fiona M. Mensching, Alba Sanchis-Juan, Jack M. Fu, Isaac Wong, Xuefang Zhao, M. Wilson, B. Weisburd, M. Lek, Hugo Abarca-Barriga, C. Al-Haddad, Jeffrey Berman, E. Bothun, J. Capasso, O. Chacón-Camacho, Lan-Yun Chang, Stephen P Christiansen, M. Ciccarelli, M. Cordonnier, G. F. Cox, Cynthia J. Curry, L. Dagi, Thomas Lee Dahm, Karen David, B. Davitt, T. de Berardinis, J. Demer, J. Desir, F. D’Esposito, A. Drack, Eric Eggenberger, J. Elder, A. Elliott, K. Epley, H. Feldman, Carlos R. Ferreira, Maree P. Flaherty, A. B. Fulton, C. Gerth-Kahlert, I. Gottlob, Stephen Grill, D. Halliday, F. Hanisch, Eleanor Hay, G. Heidary, C. Holder, Jonathan C. Horton, A. Iannaccone, Sherwin J. Isenberg, S. Johnston, A. Kahana, J. Katowitz, M. Kazlas, Natalie C Kerr, Virginia E. Kimonis, M. Ko, Feray Koç, D. Larsen, G. Lay-Son, D. Ledoux, Alex V Levin, Richard Levy, Christopher J. Lyons, D. Mackey, Adriano Magli, Iason S. Mantagos, Candice Marti, I. Maystadt, Fiona McKenzie, Manoj P Menezes, Claudia N. Mikail, David T. Miller, K. B. Miller, M. Mills, K. Miyana, H. U. Møller, L. Mullineaux, J. Nishimura, A. Noble, P. K. Pandey, Piero Pavone, Johann Penzien, R. Petersen, James A. Phalen, A. Poduri, C. R. Polo, L. Prasov, F. Ramos, Maria Ramos-Cáceres, Richard M. Robb, Béatrice Rossillion, Mustafa Sahin, Harvey S Singer, Lois E. H. Smith, J. A. Sorkin, J. Soul, S. Staffieri, Heather Stalker, S. Stasheff, Sonya Strassberg, Mitchell B. Strominger, D. Taranath, Ioan T. Thomas, Elias I. Traboulsi, M. C. Ugrin, Deborah K. Vanderveen, Andrea L. Vincent, Marlene C. Vogel G, B. Wabbels, A. Wong, C. Woods, Carolyn Wu, Edward Yang, A. Yeung, Terri L. Young, J. Zenteno, Alexandra A. Zubcov-Iwantscheff, Johan Zwaan, Harrison Brand, M. Talkowski, D. MacArthur, A. O’Donnell-Luria, C. Robson, David G. Hunter, and Elizabeth C. Engle. Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders. Genetics in medicine : official journal of the American College of Medical Genetics, 27:101216-101216, Jul 2025. URL: https://doi.org/10.1016/j.gim.2024.101216, doi:10.1016/j.gim.2024.101216. This article has 20 citations.
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 6 |
| Resolved | 6 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 6 |
| On topic | 2 |
| Off topic | 0 |
All extracted references resolved successfully.